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Abstract
Laura Christine Sparks
DEVELOPMENT AND CHARACTERIZATION OF PHOSPHOLIPID ENCAPSULATED
QUANTUM DOT CONSTRUCTS FOR BIOLOGIC APPLICATIONS
The American Cancer Society predicts that 577,190 cancer-related deaths and 1,638,910 newly
diagnosed cases of cancer will occur in 2012. As these statistics show, cancer is a prevalent and
devastating health issue; determined by the Mayo Clinic to be the second leading cause of death
in the United States. Skin cancer is the most common form of cancer in the United States. In
2012 more than 68,000 Americans will be diagnosed with melanoma, 48,000 will be diagnosed
with an early form of the disease that has not yet reached the lower levels of the epidermis, and
more than 2 million people will be treated for basal cell or squamous cell skin cancer. Early and
accurate detection is the most reliable way to ensure a positive outcome and the ultimate survival
of the patient. As the most aggressive form of skin cancer, survival of melanoma is especially
connected to early detection. Current methods for the initial detection of potential cancerous
masses and lesions rely on visual examination, palpitation, and biopsy. Accurate determination
of the presence of cancerous cells in a biopsy is especially difficult at the early stages when only
a small percentage of cells in the biopsied mass show the morphological traits associated with
being cancerous. This circumstance often results in a false negative (FN), delaying the necessary
treatment until the cancer has reached a more developed stage. Developing more accurate
methods for the detection of cancerous cells within a biopsy would aid in alleviating this
problem. An improvement to the conventional method of visually examining biopsied tissues for
the presence of cells with abnormal morphologies can be offered by utilizing the model of
functionalized quantum dot (QD) constructs.
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Quantum dots are nano-particles composed of semi-conducting materials that fluoresce at
discrete wavelengths when irradiated by a high energy UV source. QD constructs are cadmiumselenium/zinc-sulfide (CdSe/ZnS) quantum dots encapsulated within a bovine derived milk
phospholipid micelle. QD constructs provide a potential mechanism for the identification of
cancerous cells within a biopsy. Appreciating the scope of the clinical problem and
understanding the potential of QDs, the objective of this thesis is to develop a primary model for
the solubilization, encapsulation, and primary phospholipid functionalization of two distinct sizes
of CdSe/ZnS QDs. The first stage of this thesis optimized the currently utilized protocol for
synthesizing cadmium-selenium (CdSe) quantum dots to develop a set of parameters for
consistently producing white fluorescing CdSe cores (WFCs) and CdSe/ZnS QDs of 505nm and
555nm (+/- 10nm). The application of synthesis times, temperatures, and quenching methods
were employed to achieve this. The second stage developed a phospholipid encapsulation
method for the initial functionalization and suspension of the hydrophobic QDs in aqueous
media via encapsulation within phospholipid micelles. The final stage of this thesis focused on
the successful introduction of the QD constructs into keratinocyte cells. Calcein and Ethidium
homodimer-1 stains were applied to determine cell viability, Histochoice was applied as a
fixative, and Hoechst staining was employed for cell nuclei identification. Analysis using
confocal microscopy suggests successful attachment of QD constructs, in 0.1% w/v keratinocyte
media, to the exterior of keratinocyte cell membranes with a 30% average cell survival rate at 24
hours after sample introduction. Future research investigating the interaction of QD constructs
with biologic mediums of greater physiological complexity, as well as application of a secondary
functionalization, are the next steps on the path toward achieving a viable mechanism for
targeting and identifying cancerous cells within a biopsy.
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Chapter 1 – Introduction

1.1 Motivation
According to the 2012 cancer statistics conducted by the American Cancer Society it is
expected that 1,638,910 new cases of cancer will be diagnosed in 2012 (1). Additionally it is
expected that 577,190 deaths will occur within the diagnosed population currently living with
cancer (1). As these statistics show, cancer is a prevalent and devastating health issue and the
second leading cause of death in the United States (2). Cancerous tumors can grow quickly,
increasing their rate of cell proliferation, and metastasize to other areas of the body. If gone
undetected, until the later stages of development, it is often too late for the patient to survive (3).
The most common type of cancer found in the United States is skin cancer (4). In 2012 more than
68,000 Americans will be diagnosed with melanoma, 48,000 will be diagnosed with an early form
of the disease that has not yet reached the lower levels of the epidermis, and more than 2 million
people will be treated for basal cell or squamous cell skin cancer (4).
Early and accurate detection is the most reliable way to ensure a positive outcome and the
ultimate survival of the patient (5). As the most aggressive form of skin cancer, once metastasis
has occurred, survival of melanoma is especially connected to early detection (6). Current methods
for the initial detection of potential cancerous masses and lesions rely on visual examination,
palpitation, and for the most prevalent forms of cancer, annual screenings (5). Once the presence of
cancerous tissue has been ascertained by a physician a biopsy is performed for confirmation. Initial
confirmation of cancerous cells is based on visual inspection of the cells under a microscope by a
pathologist (7). In cases where an initial assessment is used as the basis for dictating which
treatment options will be followed, it is important that the evaluation of the biopsy be accurate.
Accurate determination of the presence of cancerous cells in a biopsy is especially difficult at the
1

early stages when only a small percentage of cells in the biopsied mass show the morphological
traits associated with being cancerous. This circumstance often results in a false negative (FN),
delaying the necessary treatment until the cancer has reached a more developed stage (8).
This propensity for FNs in the early stages of cancer development indicates there is a need
for an ulterior method of identification that would recognize even a single cancerous cell.
An improvement to the conventional method of visually examining biopsied tissues for the
presence of cells with abnormal morphologies can be offered by utilizing the model of
functionalized quantum dot (QD) constructs. QD constructs provide a mechanism in which
cancerous cells present within a biopsy sample could potentially be detected.
Quantum dots made soluble and functionalized to target enzymes associated with specific
cellular receptors are currently being used as replacements for organic fluorphores in biologic
applications of cellular tagging and tissue mapping (9-13). Applying this same methodology
toward targeting enzymes that are associated with the initial stages of growth and proliferation
specific to cancerous cells provides a platform for detecting the onset of cancer at the initial phase
of cellular manifestation; developing the capability to detect the presence of cancerous cells at their
earliest stages of development, before the tumor reaches the stage of metastization, would greatly
increase patient outcome and survival. In the last decade there have been several approaches for
targeting cancer cells utilizing QDs. One such approach explored by Gao et al. in 2004 involved
the encapsulation of QDs with an amphiphilic tri-block polymer and multifunctionalization of the
encapsulated QDs with a prostate-specific membrane antigen (PSMA), a cell surface marker
associated with prostate epithelial cells (9). In the Gao approach anti-body conjugation of the
polymer encapsulated QDs was used for in vivo active tumor targeting. In 2008 an investigation
into the creation and use of proximity activated nanoparticles utilizing a QD base and a
fluorescently labeled cleavable peptide substrate modeled in an in vitro environment was
2

conducted by Smith et al. (10). Smith’s group synthesized carboxylated CdSe/ZnS QDs
bioconjugated with a cleavable peptide substrate specific to matrix metalloproteases (MMPs). The
goal of each of these methods was to develop a method for cancer targeting, drug delivery, and
imaging using QDs.
The purpose of this thesis was to develop a base model for the solubilization, encapsulation,
and primary functionalization of QDs using phospholipids as both the encapsulation and
functionalization component. The methods for phospholipid encapsulation of QDs described in the
following chapters were developed using the phospholipid encapsulation methods outlined by Fan
and Carion in their 2002 and 2007 papers detailing the use of such constructs in applications of in
vivo imaging. It is proposed that the basic method for the phospholipid encapsulation of QDs
described in this thesis can be further modified to target additional cellular components through a
secondary functionalization. These secondary functionalized QD constructs would provide a useful
method for targeting and imaging cells of interest for future in vitro and in vivo studies. Further,
secondary functionalization could then be fine-tuned to effectively create cell specific targeting
constructs with the potential for use as an efficient and consistent mechanism for seeking out and
confirming the presence of cancerous cells in in vitro studies.
This introduction will begin by presenting a fundamental overview of the physiology and
stages of the development of cancerous cells, focusing specifically on melanoma. General
components of the characteristic properties of UV radiation, as well as particular aspects pertaining
to the effects of UV radiation on epidermal tissue, will also be discussed as well as a brief overview
of epidermal physiology. Additionally, the chemical properties and biological interactions of
phospholipids, and the physics related to the behavior of quantum dot will be provided.
Understanding the chemical and biological interactions characteristic of phospholipids will give
meaningful insight into the purpose for each step of the QD construct development process.
3

Although a detailed knowledge of the physics behind the behavior of quantum dots is not essential
for their creation, it is, I believe, a valuable and thoroughly interesting aspect of the process and
therefore should not be neglected for the sake of brevity. Finally, in this introduction a concise
summary of some of the alternative biologic applications for which QDs are currently being used
will be provided in order to give a proper appreciation for the diverse and complex environment
into which this thesis attempts to delve.
1.2 Cancer
Tumor is the general term used to describe a number of diseases that are characterized by
the rapid and uncontrolled division of mutated cells. The source of this abnormal growth of body
tissue is called the neoplasm (14). Normal cell cycles contain stages of controlled cell growth and
proliferation as well as coordinated cell death referred to as apoptosis. The natural proliferation
cycle of cells exists to create replacements for old or damaged cells and to compensate for nonpathological deficits which may occur. Cells that are old or damaged undergo a natural and
automatic cell death thereby letting newer cells take over their biologic processes (14). The control
for each of these processes is encoded in the DNA within the cell’s genes. The balance of cell
proliferation and apoptosis is altered as a result of multiple mutations in the DNA code over time
(15). As a consequence of this prolonged imbalance a tumor develops. Classifying the cell as
cancerous pertains to it having the characteristic of being malignant. A malignant tumor will
infiltrate adjacent tissues as well as exhibit cell detachment from its initial location of origin, the
neoplasm, move through blood vessels and the lymphatic system, and migrate to tissues and organs
throughout the rest of the body (16). Tumors that do not exhibit these invasive characteristics are
referred to as benign. This process of migration and infection is called metastasis. Metastasis is the
greatest threat to the health and survival of the patient and is subsequently the most detrimental
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characteristic of cancer (17). Although metastasis of a melanoma can occur quickly, it is not
immediate. There are eight defined stages of metastasis beginning with the primary tumor.

Figure 1.1 The eight stages of tumor growth and expansion leading up to metastasis (17).

The first stage is characterized by the primary growth of the neoplastic cells; at this stage
the tumor expands. Proliferation and angiogenesis dominate the second stage. In order for the
tumor to expand beyond a diameter of 2mm vascularization must occur. For every increase in the
amount of cellular proliferation a corresponding increase in new capillary formation must also
occur (18). Following capillary development tumor cells will begin to detach from the primary
mass and penetrate the surrounding healthy tissue eventually reaching a blood vessel (19). Once
the blood vessel has been reached the cancer cells are transported throughout the body and proceed
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to attach to the capillary beds of other tissues and organs where the metastasizing tumor cell will
breach the endothelial cell barrier and invade (19,20).
There are a number of risk factors associated with developing cancer, they fall into two
categories: environmental and genetic. Environmental factors encompass anything not strictly
considered to be genetic. Some examples of environmental factors are chemicals, food, infection,
radiation, obesity, cigarette smoking, stress, artificial tanning, and sunlight (21). Skin cancer is
especially associated with UV damage as the result of long term sun exposure (4). Genetic factors
include fair skin, previous melanoma, and a family history of cancer. Several genetic mutations in
genes responsible for controlling cell growth can lead to tumor development. These mutations,
such as BRCA1 and BRCA2 mutations related to breast and ovarian cancer, have been found to be
hereditary (22).
1.2.1 Diagnosis of Skin Cancer
Current methods for assessing the type of tumor cell, benign or malignant, start with a
biopsy. Skin biopsies are implemented in one of four ways. The choice of biopsy type is dependent
upon the initial visual assessment of the lesion. Shave biopsies involve the use of a thin blade to
shave off the uppermost layer of the area in question. Punch biopsies implement a sharp hollow
circular tool to extract a thick section of the skin containing the first few top layers. An incisional
biopsy employs a scalpel to remove a partial section of the growth and an excisional biopsy uses a
scalpel to remove all of the growth including a portion of the surrounding tissue (4).
Each of the three types of skin cancer are a the result of mutations within a specific type or
layer of the epidermis: squamous cell carcinoma develops from mutations in the keratinocytes of
the stratum spinosum, basal cell carcinoma results from mutations of cells within the stratum
basale, and cancerous melanoma develops from mutations within melanocyte cells.
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Figure 1.2 The epidermal and dermal layers of the skin with a magnified view of the epidermal
layer in which the squamous cell, basal cell, and melanocyte reside (21).
Of these three, basal cell carcinoma (BSC) is the most common but also the least dangerous (23).
BSC is classified as a non-melanoma cancer as a result of its extremely low probability for
metastasis (24). BSC develops in the stratum basale, a single layer of stem cells and keratinocytes
intermixed with melanocytes and tactile cells. The stratum basale layer is the deepest layer of the
epidermis, resting on the basement membrane just above the dermis. In cases of BSC, the lesion
begins as a “small shiny bump” and upon enlargement will acquire a depression at its center. If
allowed to progress the lesion will eventually invade the dermis (24). Squamous cell carcinoma
(SCC) presents as rough, scaly, flat, reddish patches and most often affects those of fair
complexion and extended chemical or sun exposure over their lifetime (25). SCC develops in the
keratinocytes of the stratum spinosum and without treatment may eventually metastasize to the
lymph nodes (24). Melanoma is the deadliest skin cancer as a result of its high rate of metastasis
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and is therefore the leading cause of skin disease related death, but constitutes only 5% of the total
cases of skin cancer (26, 24). Melanoma is caused by mutations in the melanocytes ordinarily
responsible for producing the pigment melanin.
1.2.2 UV Radiation
The electromagnetic (EM) spectrum encompasses the entire range of known radiation
energies starting with the most energetic forms, gamma, x-ray, and UV, and progressing to the least
energetic forms such as infrared and radio waves (27). The energy radiated from a source is
directly linked to the wavelength of the emitted radiation measured in units of nanometers (nm).
The longer the wavelength of the emitted radiation, the lower the associated energy of the emitted
radiation, conversely, a shorter wavelength of emitted radiation will result in a higher energy and
therefore the more harmful the effects of the emitted radiation.

Figure 1.3 The electromagnetic spectrum (28).

The EM spectrum range, in order of lowest to highest energy, is: radio waves, microwaves,
infrared, visible, ultraviolet (UV), x-rays, and gamma rays (27). The UV range of the spectrum can
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be further divided into near UV (UVA), far UV (UVB), and extreme UV (UVC) (36, 37). The most
prevalent source of UV radiation is the sun. UVC radiation has a wavelength between 100 -290 nm
and is completely blocked from reaching the surface of the Earth as a result of the ozone layer of
the atmosphere absorbing the radiation (37). UVB rays, 290-320nm, are partially absorbed by the
ozone layer and are therefore partially transmitted to the surface. UVA, (320-400nm) rays pass
through the ozone layer without any attenuation and are thereby fully transmitted to the surface of
the Earth (37). Although UVB radiation has been determined to be the more carcinogenic of the
two, extended exposure to both UVA and UVB radiation, results in damage to DNA thereby
causing mutations which may lead to the formation of melanomas (38).
1.3 The Epidermis
The skin is the largest organ of the human body, making up roughly 15% of total body
weight and covering a surface area of 1.5 to 2.0m2 in adults (24). Skin is composed of two layers,
the epidermis and the dermis; the epidermis being the outermost of the two. One of the main
functions of the epidermis is to act as a barrier to the harmful effects of UV radiation (24). In this
capacity the epidermis protects the deeper tissue layers form exposure to the damaging UVA and
UVB rays. The epidermis consists of a series of cell layers, each containing keratinocyte cells in
various states of growth and viability. Keratinocytes make up the majority of the cells found in the
epidermis, approximately 90%, and are named as a result of their primary function of synthesizing
keratin (24, 39).
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Figure 1.4 The five layers of the epidermis and the cells that comprise each layer (39).
Keratinocytes, originating in the stratum basale layer as a product of stem cell and
keratinocyte cell mitosis, migrate upwards through each subsequent layer of the epidermis toward
the surface where the replace damaged or dead epidermal cells in a 30 to 40 day cycle of
regeneration (24).During the migration process the shape and function of the keratinocyte cells
changes. As they move up through the layers they become flatter and produce a lipid-filled
membrane-coating vesicle that aids in waterproofing the epidermal surface (24). Continued
exposure of epidermal cells to UV radiation can lead to mutations, which over time can begin
affecting the cells ability to control proliferation leading to the formation of cancerous lesions.
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1.4 Phospholipids
The plasma membranes of cells separate intracellular components from extracellular
components as a means of maintaining the environment necessary for cellular function. The plasma
membrane is composed of a phospholipid and phosphoglyceride bilayer integrated with a variety of
associated proteins (40). A phospholipid is an amphiphilic molecule comprised of a polar
hydrophilic head and two non-polar hydrophobic acyl fatty chains (40). The hydrophobic heads of
the phospholipid are positioned outward creating both the intracellular and extracellular surfaces of
the membrane. The hydrophilic acyl fatty chains are directed inward and embedded within the
membrane layer.

Figure 1.5 Phospholipid molecular structure and aggregation formation in the presence of water
(41).

The species designation of phospholipid is dependent upon the particular alcohol either
attached to or forming the primary backbone of the molecule. In the case of phosphatidylcholine
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(PC), phosphatidylserine (PS), phosphatidylinositol (PI) and phosphatidylethanolamine (PE), their
alcohols are attached to the glycerol backbone of the molecule. Unlike PC, PS, PI, and PE, the
alcohol of the phospholipid sphingomyelin (SP) is the backbone of the molecule (40). The
phospholipid composition of the membranes allows for diffusion within the plane of the membrane
(40). It is this quality, promoting the integration of other phospholipid based structures, that can be
exploited in the effort to tag and map tissue using phospholipid encapsulated QDs constructs.
Additionally phospholipids can be altered to contain specific functional headgroups such as poly
ethylene glycol (PEG) and amines (-NH2) to increase the biocompatibility of the phospholipids and
provide additional sites for further bioconjugation (11). As a result of the amphiphilic nature of the
phospholipids, one hydrophobic end and one hydrophilic end, they are especially useful as a
material for encapsulating the normally toxic and hydrophobic inorganic CdSe/ZnS QDs. The
amphiphilic characteristic inherent to phospholipids makes it possible for them to attach to the QDs
on one end and interact with an aqueous environment on the other end. Typically when
phospholipids are suspended in a polar nonorganic substance such as water they will spontaneously
associate to form bilayers like those illustrated in Figure 1.6 (42). When suspended in an organic
substance, such as chloroform, phospholipids become soluble at room temperature and their
hydrophobic fatty acid chains can readily attach to the like-wise hydrophobic surface of the QD.
Multiple attachments of phospholipids in this manner result in a QD that is completely
encapsulated and therefore able to become soluble in aqueous solvents.

12

Figure 1.6 Phospholipid fatty acid chain attachments to QD surface.

1.5 Quantum Dots
All materials can be characterized by their tendency to either promote the movement of
electrons through their mass, or to inhibit the movement of electrons through their mass; their
degree of electrical conductivity (43). Those that promote the movement of electrons are referred to
as conductors and those that inhibit the movement of electrons are referred to as insulators.
Intermediary between insulators and conductors are materials classified as semi-conductors. The
distinguishing characteristic between insulators, conductors, and semi-conductors is the size of
their respective band gaps.
The band gap describes the energy needed to be absorbed by an electron in order for that
electron to be excited to the conduction band, as well as the energy released by the electron when it
de-excites back to its ground state in the valence band. The relative ease of promoting an electron
from the valence band to the conduction band determines the electrical conductivity of the material
(43). The Fermi energy denotes the highest energy level occupied by an electron when at absolute
zero. Understanding the connection between atomic orbitals, electron energies, valence shells, and
band gaps is integral to understanding the fundamental phenomenon responsible for the unique
emission behavior exhibited by quantum dots.
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Figure 1.7 Variation of band gaps between the conduction and valence bands of insulators,
semiconductors, and conductors.

Insulators have empty conduction bands and a valence band full of electrons tightly bound
to their atoms by ionic or covalent bonds (44). Covalent bonding, the sharing of valence electrons
between neighboring atoms, occurs in materials composed of a single element or similar elements;
ionic bonding is the complete transfer of an electron from one atom, an electron donating metal, to
another atom, an electron accepting non-metal (45). The presence of these strong bonds between
the electron and the atom result in a large band gap, an inhibition to electrical conduction,
necessitating the need for a significant amount of energy to induce an electron to transition to the
higher energy conduction band. In the case of pure diamond 6 to 7 eV is required to excite a single
electron into the conduction band (44). Conductors possess little to no band gap between their
valence and conduction bands and often the highest available, but unoccupied, energy levels of the
valence band will overlap with the lowest empty energy levels of the conduction band. This
overlap causes the electrons within the partially filled valence band to move freely within the
material promoting conductivity (44).
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Semiconductors are a type of material characterized by their inhibition of electron
movement at low temperatures and their promotion of electron movement as more energy is put
into the material, often in the form of an increase in temperature from absolute zero, but also as the
result of incident radiation (45). The central property that defines a material as conducting,
semiconducting, or insulating is the band gap of the material. The band gap of the material is an
intrinsic property of the bulk material. The change in this intrinsic material property relative to the
number of constituent atoms, bulk state or nano-scale, is key to the fluorescent property of quantum
dots.
The Aufbau principle describes the characteristic preference of electrons to occupy the
lowest energy state possible (46). As such, electrons will fill the inner most atomic energy levels of
an atom first. Each electron occupies a specific atomic orbital, within a specific energy shell, and
the further out the energy shell is from the nucleus of the atom the greater the energy attributed to
the electrons occupying that shell (47).The highest energy level occupied by an electron, when it is
in its non-excited ground state, is the valence shell. Electrons occupying the valence shell are called
valence electrons.

Figure 1.8 Electron atomic orbital lowest energy configuration for silicon (48).
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Valence electrons have the greatest probability of being promoted to a higher energy level
(45). It is from the position of lowest energy, the valence shell, that an electron may be excited into
a higher, and as yet unoccupied, energy. Excitation will occur if the electron is acted upon, and
absorbs, an amount of energy equal to or greater than the difference in energy between the valence
shell and the next higher energy level. The exact number of electrons permitted in each energy
level and the minimum possible energy of an atom can be determined by coupling the aufbau
principle with Pauli Exclusion Principle which states, “No two electrons in a quantum system can
occupy the same quantum state” (49). Combining these two principles, unperturbed electrons will
always occupy states of lowest energy and no more than two electrons can simultaneously occupy
an atomic orbital, provides information on the exact energy of the highest energy valence electron.
Knowing the exact energy of the highest energy valence electron, while also knowing the energy of
the nearest unoccupied orbital, yields the effective band gap energy. In bulk form, the discrete
energy states of the individual atom are replaced by the continuous valence and conduction energy
bands (50). The Pauli Exclusion Principle prevents any two electrons form occupying the same
quantum energy state, therefore, when multiple atoms are in close proximity, or bounded to one
another, the discrete energy levels of the individual atoms form a band of multiple degenerate
orbitals of the same energy for which the corresponding electrons can reside (47). Figure 1.9 shows
an illustration of this progression from discrete energy levels to continuous energy bands.
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Figure 1.9 Progression from discrete energy levels to continuous energy bands during aggregation
of individual atoms to form bulk material (47).

For a material to be considered a nano-material its largest dimension must be no bigger than
100nm, conversely, a material that is larger than 100nm with respect to its smallest dimension will,
for the purposes of this thesis, be considered a bulk material (45). Quantum dots are nano-crystals
composed of semiconducting material, which as the result of their small nano-scale size, 1-10nm,
exhibit properties that are not observed in the larger bulk material. QDs have the same elemental
composition and atomic arrangement as the corresponding bulk material; however, their size causes
the number and arrangement of atomic energy levels available to electrons to be altered.
The valence and conduction bands found in the bulk material are the result of the
interaction of the electron energy levels in the constituent atoms from which the bulk material is
comprised. In the case of a bulk material, where thousands or millions of atoms are bound to one
another, energy levels of individual atoms are forced to interact with energy levels of their
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surrounding neighbors. Interaction between the electron energy levels of each atom and its nearest
neighbors are what create the continuous valence and conduction bands found in bulk materials
rather than the discrete energy levels in atoms (47). Understanding the parallels between the energy
bands that exist in the bulk material and the energy shells that exist in individual atoms will
facilitate a general understanding of the quantum mechanical effects that are a consequence of the
diminished size of QDs.
1.5.1 Quantum Confinement and the Bohr Exciton Radius
QDs have the same elemental composition and atomic arrangement (1) on the nano scale as
the corresponding bulk material, however, decreasing the physical size of a material has several
interrelated consequences: the number of atoms within the material is decreased, less bulk material
means less space for the electron-hole pair to move in thus causing confinement of the electron,
and the number of energy levels available to the electrons decreases and discrete atomic energy
levels form rather than continuous energy bands.
In semiconducting bulk materials, when a photon possessing an energy greater than or
equal to the band gap energy is absorbed, an electron will be excited in to the conduction band.
The promotion of the electron from the ground state into a higher energy state results in a
positively charged hole. Until the electron is de-excited and recombines with the hole, the pair can
move about the bulk material but will remain within a prescribed distance of one another as a result
of the Coulomb attraction between them (40). The distance between the electron and the hole is a
unique characteristic intrinsic to each material referred to as the Bohr exciton radius.
In the case of CdSe cores the average distance between the electron and corresponding hole is
5.6nm (51). If a CdSe crystal smaller than this distance is synthesized the energy is constrained and
quantum confinement of the energy will develop. A continued decrease in the size of the QD
relative to the natural electron-hole distance causes an increase in the amount of confinement and
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subsequently an increase in the band-gap energy. Increases in the band gap energy result in a
transition from the continuous energy bands of the bulk material back toward the discrete energy
levels seen in atoms. This atom-like resemblance of the discrete energy levels of QDs has
promoted use of the term “artificial atom” when referring to QDs (51).

Figure 1.10 Relationship between size, Bohr exciton radius, band gap and composition of atomic
energy levels.

The progression of electron movement restriction leading to quantum confinement can be
accomplished in two ways: physical reduction in the size of the material or trapping the material
between layers of a second material with a larger band gap energy. As the physical size of the
material is decreased, composed of fewer and fewer atoms, the energy states of the atoms are no
longer as compressed, they lose the continuous quality found in the band gaps of the bulk material,
they start to spread out and become more discrete. A standard illustration for the change in energy
states of a material as the size of the material decreases is given in Figure 1.11. In the bulk
material, referred to as 3D, the energy state is continuous, the electron can move in all three
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dimensions. By restraining the electron transitions in one dimension, either by the physical removal
of the bulk material or by using a secondary material with a larger band gap, the electrons are now
confined to two dimensions. This confinement alters the manner in which the electron energy states
interact, creating distinctions between each energy state. As we continue on, the states become
more well-defined until finally they exhibit the same discrete quality as individual atoms.

Figure 1.11 Progression of energy state densities as a result of increased electron energy
confinement.

This transition toward discrete energies associated with a reduction in the size of the
material is directly related to the aforementioned Bohr exciton radius. When the size of the material
is less than the distance of the exciton radius, the electron’s wave-function is constrained and the
subsequent effect is an increase in the band gap (52). As the size decreases, the electron wave
function becomes ever-more confined, as the electron wave function becomes ever-more confined
the band gap energy increases, and as the band gap energy increases the energy needed to excite an
electron from the valence to the conduction band also increases; each of which result in the
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increased energy of the emitted photon. Keeping these relationships in mind, the connection
between QD size and photon emission wavelength can be made. Relative to the electromagnetic
spectrum, the higher the energy of the emitted photon the more shifted toward the blue end of the
spectrum and the lower energy more toward the red. Figure 1.12 illustrates this connection between
QD size and emission wavelength. The basic break down being, small QDs have bigger band gap
energies, bigger band gap energies result in higher energy emitted photons, therefore the energy of
the emitted photon is directly related to the size of the QD; by synthesizing QDs of a specific size
you can tune the wavelength of emitted light.

Figure 1.12 Relationship of QD size band gap energy and photon emission wavelength.

1.5.2 Biologic Quantum Dot Applications
Current Biomedical QD applications for QDs include membrane labeling, fluorescent
microscopy, antibody tagging, genomic analysis, metabolic analysis, and diagnosis of metabolic
processes (10-13, 53, 54). QDs are promising substitutes for organic fluorophores in many of the
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biologic applications involving membrane labeling, fluorescent microscopy, and antibody tagging.
One of the most prominent advantages of using QDs over their organic counterparts is the QDs
reduced tendency to photo-bleach and the possibility for exciting multiple QDs of different
emission wavelengths with the same excitation source. This capability to use a single excitation
source for multiple QDs facilitates imaging of samples in which there are several components of
interest. QDs are being used in genomic applications as well. Samples containing different
combinations of QDs with distinct emission spectra conjugated to different DNA probes are mixed
in a solution with a target DNA containing complementary sequences (55). The hope is that this
process can be fine-tuned for detecting the presence of genetic defects. Similarly, viral analysis can
be undertaken using what is referred to as QD bar codes - ten different QD colors could
conceptually provide 45 different QD pair combinations (56, 57). The discrete wavelengths of QD
emission make this possible, specifically tailoring them through functionalization to target multiple
sites upon a tumor increasing the probability of detecting even the smallest amounts of cancerous
cells. QD-fluorescent dye conjugates are also proposed as tools in the diagnosis of metabolic
processes. They provide a way to monitor the proteolytic activity of extracellular matrix
metalloproteinases (58, 59). These examples are a small sample of the variety of biologic
applications in which the use of QDS has started to become common place; a range of applications
that is increasing every day.

1.6

Overview of Thesis Goals and Deliverables
This introductory chapter has served as a vehicle for providing the foundational knowledge

and background pertinent to this thesis. The clinical problem of detecting and diagnosing cancer at
the earliest stages of development is, in cases of the most aggressive forms of cancer, paramount to
patient survival. False negatives which may occur during the examination of biopsied lesions are
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counterproductive to the goal of early detection. Current methods relying on visual examination of
biopsied samples viewed under a microscope are inadequate for detecting small populations of the
abnormal cells indicative of cancer. A more adequate method of detection is required;
functionalized QD constructs are a mechanism which can be employed to fill this need. QD
constructs have the potential to not only identify and target cancerous cells, but eventually to also
be used simultaneously as drug delivery devices.
The purpose of this thesis was to develop a foundational method for the solubilization and
primary functionalization of QDs to be used in biologic tagging. This was accomplished through
encapsulation of QDs of different emission wavelengths within phospholipid micelles. To achieve
this, CdSe QDs were synthesized using the standard Cal Poly QD synthesis protocol with minor
modifications in synthesis temperature and reaction time to achieve QDs of the desired emission
wavelengths. These CdSe QDs were then coated in ZnS shells at a variety of synthesis
temperatures to once again produce QDs with an emission wavelength specific to the necessary
testing parameters. Fluorescence spectra were used to assess the center max wavelengths (CMWs),
intensities, and full width at half max associated with each batch of synthesized QDs. Choice of
QDs to be encapsulated and used in the keratinocyte cell culture trials was dictated by the emission
wavelengths of the fluorescent stains applied to the keratinocyte cultures: Calcein at 517nm and
Ethidium homodimer-1 at 635nm. The QDs were then encapsulated in phospholipid micelles and
introduced to the keratinocyte cultures of varying periods of time. This thesis offers a first method
for the solubilization and primary phospholipid functionalization of QDs for introduction to
keratinocyte cells that can be further modified for future applications.
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Chapter 2 – Development and Evaluation of CdSe/ZnS Quantum Dots

2.1 Introduction
In 1970 Japanese physicists Esaki and Tsu were the first to produce crystalline superlattices
possessing near perfect match of lattice constants leading to the creation of a two dimensional
structure with previously unseen electronic properties (60, 61). Also in the early 1970s researchers
at AT&T Bell Laboratories and IBM began making 2D quantum wells using semiconducting
materials (62). In 1984 Miller et. al. at AT&T Bell Laboratories in New Jersey published research
on the shifts in optical absorbance experimentally found in GaAs-AlGaAs quantum well structures
contrasting the effects with bulk semiconductors as a “consequence of quantum confinement
carriers” (63). Louis E. Brus of AT&T Bell Laboratories discovered quantum dots in colloidal
solutions, at the same time Efros and Ekimov at the A.F. Ioffe Physical-Technical Institute in St.
Petersburg Russia were also developing semiconducting nanocrystal technology, first discovered in
a glass matrix, which was later christened “quantum dots” by Mark A. Reed in 1988 (64, 65). In
the early 1990s the field nanocrystal research was expanding and synthesis using both top down
and bottom up techniques were being employed by multitudes of researchers.
The top down approach involves working with a macroscopic volume of material and
gradually and precisely decreasing its size, either through mechanical or chemical means, until the
nanoscale, approximately 100nm, has been reached. The top down process is akin to that of a
whittler slowly shaving down a hunk of wood into a delicately carved miniature rocking chair (66).
The top down approach to synthesizing QDs, though effective, is time consuming and expensive
(67).
Bottom up approaches include self-assembly, colloidal synthesis, and guided attachment of
colloidally synthesized QDs through plasma lithography (67). Self-assembly of QDs can be
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achieved by electron beam lithography, a physical mechanism by which an electron beam etches
grooves into a substrate that are then filled by the semiconducting material, molecular beam
epitaxy (MBE) where the semiconducting materials are heated to the point of vaporization and
condensed and reacted on a substrate, or metal-organo chemical vapor deposition (MOCVD), a
chemical mechanism in which the atomic deposition of one semiconducting material is applied on
to a substrate of a second semiconducting material (68). Through natural processes involving the
energetic stability associated with lower energy states the deposited material forms nanometer
sized beads on the surface of the substrate. The final QD nanocrystals are produced by layering the
beads with a semiconducting material possessing a band gap larger than that of the bead material
(69). An added benefit to self-assembled or colloidally synthesized QDs using a bottom up
approach, aside from faster synthesis time and decreased cost of materials, is that the resulting QDs
have smaller diameters, and subsequently stronger quantum confinement potentials, than QDs
synthesized using one of the top down approaches (69).
By the late 1990s the synthesis had shifted away from using the initial toxic and air-reactive
chemicals toward “green synthesis” utilizing still biologically toxic but less hazardous and more
stable reagents. Interest in the field of nanocrystals and quantum dots and their varied applications
has grown exponentially over the last three decades as is evident from the number of related
research published in journals; almost none pre-1980 to over 3500 per year by 2009 (64). Although
research continues in both the top down and bottom up synthesis of quantum dots, the bottom up
approach has overtaken in popularity.
As mentioned in Chapter 1, a variety of different starting materials are available and have
been utilized for the synthesis of QD nanocrystals. Both the top down and the bottom up methods
create QD nanocrystals that are composed of atoms from groups II – IV or III – V elements that are
found in the periodic table, such as CdSe, CdTe, CdS, and ZnSe for groups II – IV, and InP and
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InAs for groups III – V (70). Of the many available semiconducting materials, the CdSe/ZnS
core/shell combination has been in use in the colloidal synthesis of QDs the longest, since 1996
(71). The most well-known and commonly used protocols for the colloidal synthesis of quantum
dots use the “green synthesis” variety of Cd/Se compounds as the semiconducting starting material
(72). The number of readily accessible articles outlining the numerous variations on the original
protocol developed by Murray et al (73) is evidence of the interest and developing usefulness of
QD involved applications.
A standard CdSe core synthesis procedure from the 2005 paper “A Safer, Easier, Faster
Synthesis for CdSe Quantum Dot Nanocrystal” written by Nordell et. al. had been previously
developed for use at Cal Poly by Aarron Lichtner in 2009 (74). The procedure was later expanded
upon to include a ZnS coating step for increased quantum yield and stability. The currently used
ZnS coating protocol was initially developed from literature by Cal Poly graduate student Sabrina
Bruce-Akman in 2010 and later refined by Josh Angell in 2011. The effects of altering the nonreagent related parameters for synthesizing CdSe cores and applying the standard ZnS coating
procedure were further investigated and modified for the purposes of this thesis. The previously
developed Cal Poly standard synthesis procedure, in its entirety, can be found in appendix B.1 or
Josh Angell’s 2011 thesis Synthesis and Characterization of CdSe – ZnS Core – Shell Quantum
Dots for Increased Quantum Yield. The previously developed bottom up colloidally synthesized
CdSe/ZnS QD Cal Poly procedure was modified to achieve the QDs with the necessary emission
wavelengths for tagging and mapping a biologic using phospholipid encapsulated QD constructs.
For the purpose of tagging and mapping a biologic it was essential to have at least two sizes of
QDs; to have QDs with two distinct and distinguishable emission wavelengths. For this reason
knowledge of, and familiarity with, the QD synthesis process was necessary for maintaining a
continuous supply of QDs for use in the phospholipid encapsulation procedure. Likewise it was
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important that the synthesis of the QDs be consistent and well documented. From the initial
procedure, optimized protocols for the synthesis of white CdSe cores and shelled CdSe/ZnS QDs
with emission wavelengths of 505nm (+/- 10nm) and 555nm (+/-) 10nm were developed. The
resulting synthesized CdSe/ZnS QDs were used in the encapsulation procedure described in
chapter 3.

2.2 Methods
2.2.1 Synthesis of CdSe cores
Synthesis of the CdSe cores applied the same reagents and amounts of reagents as described
in the standard Cal Poly protocol. Each of the precursors, selenium trioctylphosphine (Se-TOP) and
cadmium (Cd), were synthesized following the steps in the protocol, with only slight modifications
pertaining to the method for measuring out appropriate quantities of each of the dry reagents. The
standard procedure weighed out 33mg of selenium powder or 13mg of the cadmium oxide powder,
into a plastic weigh-boat and then transferred the powder into a 50mL round bottom flask. The
method used in this thesis was to directly transfer the powder into the two neck 50mL round
bottom reaction flask. The standard synthesis of the Se-TOP precursor yields a 5.4mL volume of
the precursor. The Se-TOP precursor for this work was synthesized in quintuple batches to reduce
the variation across the multiple CdSe core synthesis procedures. Se-TOP precursor older than five
days was discarded for use in core synthesis beyond the initial experimental trials. The size of the
Cd precursor batch was dependent on the size and number of samples to be extracted. For one or
two samples, of 5mL each, a single batch was made; for extractions of three or more samples a
double batch was made. During the initial testing of synthesis parameters, a quintuple batch of Cd
precursor was made and divided up into 10mL volumes for synthesis of the CdSe cores using a
stock solution. This was done in an effort to eliminate additional variables during testing of
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experimental parameters. For both the Se-TOP and Cd precursor synthesis, all reagents were
purged with nitrogen gas and vented simultaneously for a period of ten minutes. After combination
of all reagents into the reaction flask the Nitrogen and vent needles were removed to prevent
evaporation of the solution. For synthesis of the CdSe cores the Cd precursor was heated to the
desired reaction temperature and upon reaching the reaction temperature the room temperature SeTOP precursor was added. The ratio of Cd to Se-TOP precursor used in each synthesis was the
10mL of Cd to 1mL of Se-TOP prescribed in the standard protocol. At the desired reaction times
of 0, 30, 60, or 90 seconds CdSe samples were extracted, using a non-disposable glass syringe, and
deposited into the appropriate sample vials. After each CdSe sample had cooled qualitative
examination of the sample was performed by exposure of the sample to a generic black light.
Quantitative data was then obtained using an Ocean Optics USB4000 Spectrometer to take
fluorescence readings of each sample.
2.2.1.1 Experimental Variables Investigated for the General Synthesis of CdSe Cores
Four variables were manipulated in the synthesis of the CdSe cores: temperature, reaction
time, receptacle volume, and quenching. The temperature of the Cd precursor at the time of SeTOP injection was altered from the standard 225°C typically used, to 220, 215, and 210°C. Two
consequences resulted from the change in temperature; the obvious and primary effect was a
decrease in the temperature at the time of Se-TOP injection. A secondary effect was a reduction in
the time that the Cd precursor was exposed to heat before injection. It took less time for the Cd
precursor to heat up to 220, 215, or 210°C, approximately 4 minutes less for each five degree
interval, providing a reduction in the overall time of exposure to heat. The reaction time of the
CdSe core synthesis was defined as the time from complete injection of the Se-TOP into the heated
Cd until the beginning of extraction into the glass syringe. Samples were extracted at times of 0,
30, 60, and 90 seconds. The receptacle volume ranged from 2mL to 15mL with vial diameters of 1,
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1.5, 2, and 2.5cm. Variation of sample vial size was investigated to determine if heat dissipation
could be improved. A variety of vial arrangements and configurations were designed that would
provide alternate sample distributions for cooling. Along with altering the volumes of samples as a
method to assist in heat dissipation, quenching methods were investigated. Comparisons of the
differences in center max wavelength (CMW), peak intensity, and full width at half max (FWHM)
of the fluorescence spectrums for samples cooled in air, the standard, and acetone were made for
three time points: 30, 60, and 90 seconds. Quenching with acetone was carried out by flushing the
outside of the vials with acetone. For a period of one minute the sample vials were lowered into
and raised out of an acetone bath in 5 second intervals and then submerged for 3 minutes. On
occasion if the vials were submerged longer than 3 minutes the CdSe solution inside would develop
a slushy consistency.

Figure 2.1 Three sample vial arrangement used to test the effects of volume size on CdSe
fluorescence spectra. From left to right: 15mL 2.5cm, 2mL 1cm, and 10mL 1.5cm diameter glass
sample vials in an acetone bath.

2.2.1.2 Synthesis of White Fluorescing CdSe Cores (WFCs)
The same four variables were manipulated in the synthesis of the white fluorescing CdSe
cores (WFCs). The two parameters particularly focused on were reaction time and quenching.
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The entire process of extracting the sample from the reaction flask to injecting it into the glass
sample vial averaged 10 seconds. Reaction times varied between 0 and 15 seconds.
A 5cc glass syringe was used for extraction of the WFC samples. Practice and patience was
required to remove the sample as quickly as possible. The glass extraction syringe was positioned
in the second neck of the reaction flask and upon full injection of the Se-TOP precursor into the
heated Cd precursor a 3-5mL sample was extracted and injected into 1-5 sample vials. After one
minute of flushing with acetone, the vials were left submerged in an acetone bath for 3 minutes.
2.2.2 Synthesis of ZnS Coated Quantum Dots
The process used for the coating of the CdSe cores with ZnS shells applied the same
reagents and amounts of reagents as described in the standard Cal Poly protocol. The ZnS
precursor was synthesized following the steps in the standard protocol. The standard protocol did
not specify a specific CdSe core solution to ZnS precursor ratio to be used. For the purposes of this
thesis a standard ratio of 5mL CdSe to 1mL of ZnS was applied. In the modified procedure 5mL of
CdSe core solution was added to a 50mL round bottom reaction flask; a magnetic spin vane and
temperature probe were also placed in the reaction flask. The CdSe core solution was mixed at the
synthesis heat, either 160 or 110°C, in a silicon (Si) oil bath for ten minutes. 1mL of the ZnS
precursor was added in a slow consistent drop-wise fashion over a period of 2 minutes. The
reaction was then let to proceed for an additional 8 minutes. At the conclusion of the reaction time
the solution was removed from the Si oil bath and cooled to 60°C at which point 1mL of butanol
was quickly added. The flask was then agitated side to side for 2 minutes. After each CdSe/ZnS
sample had cooled, qualitative examination of the sample was performed by exposure of the
sample to a generic black light. Quantitative data was then obtained using an Ocean Optics
USB4000 spectrometer to take fluorescence and absorbance readings of each sample.

30

2.2.2.1 Temperature Variation of CdSe/ZnS Synthesis
The effect of temperature on CMW during the synthesis of CdSe/ZnS QDs was investigated
by comparing QDs synthesized at 70°C, and 110°C in addition to the standard protocol synthesis
temperature of 160°C. In the comparison of the CMW of QDs synthesized at 70°C relative to
those synthesized at 160°C, 4 WFC samples were coated at 70°C and 4 WFC samples were coated
at 160°C. The final CMWs, intensities, and FWHMs of the samples coated at 70°C were compared
to those coated at 160°C by employing a two sample t-test. Figure 2.2 gives a schematic division of
the ten previously synthesized CdSe core samples used for the comparison of the effects of QDs
shelled at110°C and at 160°C. The ten samples consist of 5 CdSe samples fluorescing white and
five CdSe samples fluorescing green at 541nm with an intensity of 5800 counts and a FWHM of
44nm, that were combined within each set, creating two subsets each. The resulting sets provided
two WFCs shelled at110°C and at 160°C, and two 541nm samplesshelled at110°C and at 160°C
using the aforementioned shelling process. The CMWs of the resulting eight samples were then
compared to the original corresponding CdSe core solution and to each other.
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Figure 2.2 Schematic of the division of the ten previously synthesized CdSe core samples used for
the comparison of the effects of QDs shelled at110°C and at 160°C.

2.3 Results
2.3.1 Synthesis of CdSe Cores
2.3.1.1 Experimental Variables Investigated for the General Synthesis of CdSe Cores
The receptacle volume only affected the outcome of the WFCs when the smallest and
greatest volumes were compared and as a result of other possible contributing factors, could not be
quantitatively demonstrated. The data in Table 2.1 are the CMW, Intensity, and FWHM averages
of 23 different CdSe core samples used to compare the effects of the reaction temperature. Each
average was taken using a minimum of three samples and a maximum of five samples. The visual
representation of the data is given in Figure 2.3. Using the values from all of the samples for each
time point, the standard deviation was calculated, using a p-value of 0.05, and applied as a
comparison of the averages for each time point in the form of error bars. Using standard deviation
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as a measure of the degree to which each parameter was affected by the synthesis temperature, it
was initially concluded that for CdSe cores synthesized at 30, 60, and 90s time points, and cooled
in air, there was no statistically significant difference in the CMW, intensity, or FWHM.
Table 2.1 Effects of Temperature on CMW, Intensity, and FWHM for 30, 60, and 90s Samples
Cooled in Air.
CMW 30s CMW 60s CMW 90s Intensity 30s Intensity 60s Intensity 90s FWHM 30s FWHM 60s FWHM 90s
(nm)
(nm)
(nm)
(counts)
(counts)
(counts)
(nm)
(nm)
(nm)
215 ° C
225 ° C
st dev

523.5
518.3
8.2

539.4
539.3
7.4

550.5
550.7
7.6

7750
6867
2360.0

4700
4367
1942.0

2875
2833
1452.0

41.3
37.1
3.4

41.4
39
5.8

43.5
39.7
8.2

Effect of Synthesis Temperature on CdSe Cores

Arbitrary Units

1000
800
600
215 C

400

225 C
200
0
CMW
30s

CMW
60s

CMW Intensity Intensity Intensity FWHM FWHM FWHM
90s
30s
60s
90s
30s
60s
90s

Figure 2.3 Comparison of the effects of reaction temperature on the average CMWs, intensities,
and FWHMs of synthesis time points of 30, 60, and 90s samples cooled in air.

In addition to calculating the standard deviation from all of the samples for each time point,
a two sample t-test, assuming asymmetric variance, was conducted to compare the effects of
temperature on the CMW, intensity, and FWHM for each time point of CdSe samples cooled in air.
Table 2.2 gives the two-tail p-values associated with each t-test using an alpha of 0.05 and a
confidence interval of 95%. All of the t-test p-values were above the alpha value of 0.05 and
therefore the null hypothesis, which indicates the means for each sample group were equal, could
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not be rejected. Based on this, it was again concluded that the temperature difference of 10°C at
the time of injection of the Se-TOP precursor did not have a statistically significant effect on the
CMW, intensity, or FWHM for time points of 30, 60, and 90s.

Table 2.2 Two Sample t-test of Effects of Temperature on CMW, Intensity, and FWHM for Each
Reaction Time Point.

Quench
Medium

Time
(s)

Air
Air
Air

30
60
90

Samples Samples CMW Intensity FWHM
at 215 °C at 225 °C p-value p-value p-value
5
5
4

3
3
3

0.41
0.99
0.98

0.98
0.86
0.98

0.06
0.33
0.45

2.3.1.2 Temporal Effects on CMW, Intensity, and FWHM of CdSe Cores
A series of synthesis, conducted at reaction temperatures of 215 and 225°C, were performed
to determine the effect that the duration of the reaction had on the CMW, intensity, and FWHM of
the CdSe cores. Data for the CMW, Intensity, and FWHM averages of 23 different CdSe core
samples that were used to compare the effects of the reaction times are given in Table 2.3. Each
average was taken using a minimum of three samples and a maximum of five samples. The visual
representation of the data is given in Figures 2.4 and 2.5. As a result of applying t-tests, it was
previously determined that temperature did not play a statistically significant role in determining
CMW, intensity or FWHM for 30, 60, and 90s reaction time points; for this reason all of the data
points from both the 215 and the 225°C synthesis were used. The averages for the CMW, intensity,
and FWHM of each time point were compared and a value for the standard deviation was
calculated. The standard deviation was then applied in the form of error bars. The resulting data
appeared to support the conclusion that there was a significant statistical difference in the CMW,
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and intensity of the CdSe cores which was dependent on the reaction time, but not a significant
difference in the FWHM associated with each reaction time. To further support this conclusion a
single factor ANOVA test was conducted.
Table 2.3 Averages of, and Standard Deviations for, the CMW, Intensity, and FWHM of CdSe
samples for 30, 60, and 90s Reaction Times. Left: averages. Right: standard deviations.

Reaction
Time (s)
30
60
90

CMW (nm)
521
539
551

Intensity
(counts)
6838
4575
2857

FWHM
(nm)
41
41
42

Reaction
Time (s)
30
60
90

CMW
(nm)
8.2
7.4
7.6

Intensity
(counts)
2366
1942
1452

FWHM
(nm)
5
3.4
5.9

Time Averages - Effect of Reaction Time on CdSe Core
Synthesis
900
800
Arbitrary Units

700
600
500

30s

400

60s

300

90s

200
100
0
CMW

Intensity

FWHM

Figure 2.4 Combined reaction time data for 215 and 225°C, quenched in air, averaged for each
reaction time point. Standard deviations were calculated for each series of samples corresponding
to individual reaction time points.
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Comparison of the Effects of Reaction Times at 30, 60, and 90s
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Figure 2.5 Fluorescence spectrum of CdSe core solutions for 30, 60, amd 90s reaction times.

A single factor ANOVA test was employed to determine the effect of different time points
on the CMW, Intensity, and FWHM. Using the resultant p-values from the ANOVA tests it was
concluded that the null hypothesis, that the means were equal within a 0.05 alpha value, could not
be rejected for the FWHM; there was no statistically significant difference between the FWHM for
each of the different reaction times. However, there was a statistically significant difference for the
intensity and CMW of the reaction times with p-values of 0.003 and 2E-6 respectively. These
values support the conclusion that the reaction time of the CdSe core synthesis plays an integral
role in determining the CMW and intensity of the CdSe core solution.
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Table 2.4 Single Factor ANOVA Test p-values for CMW, Intensity, and FWHM of CdSe Cores at
Reaction Times of 30, 60, and 90s.

Samples Samples Samples CMW Intensity FWHM
at 30s
at 60s
at 90s p-value p-value p-value
8

8

7

2.00E-06

0.003

0.86

A series of CdSe core synthesis were conducted to illustrate the dramatic change in CMW
that different reaction times could elicit. Ten different CdSe core samples were synthesized at 0
and 60s, five samples for each reaction time, using the same starting Cd and Se-TOP stock
solutions. Figures 2.6 is a digital image of the series as it appears under a generic black light.
Figure 2.7 gives a corresponding fluorescence spectrum comparing the averaged spectrums of the
series.

Figure 2.6 Digital image of CdSe core samples synthesized at 0 (white fluorescing) and 60 seconds
(green fluorescing) viewed under black light.
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Figure 2.7 Fluorescence spectrums of averaged CdSe core sample sets synthesized at 0 (white
fluorescing) and 60 seconds (green fluorescing).
A series of comparisons were conducted using 24 CdSe samples to compare the effects of
quenching samples in acetone versus the standard procedure that employed no additional
quenching measures; the standard procedure was classified as quenching in air. A two sample t-test
was used for the comparison of acetone versus air in three different synthesis arrangements: 30s
reaction time point at an injection temperature of 215°C, 60s reaction time point at an injection
temperature of 215°C, and a 60s reaction time point at an injection temperature of 225°C. The
resulting p-values, corresponding to an alpha of 0.05, were used to determine the significance of
the data and are given in Table 2.5. The only variable that showed a statistically significant
difference, p-value less than 0.05, was the intensity for the sample set with the 30s reaction time
synthesized at 215°C. There are three explanations for this: the sample sized used was too small to
yield an accurate representation of the effects and/or the effects are only significant at smaller
reaction times, or the results are accurate. Each sample set contained a minimum of three samples,
as three samples are traditionally the very minimum number required to conduct a legitimate t-test;
it is possible that a larger sample set would alter the corresponding p-values. If the effect of
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quenching with acetone is only significant at shorter reaction times, including data from samples
synthesized at a reaction time of 15 seconds could aid in supporting such a conclusion. If the data is
accurate as is, then the conclusion based on the p-values is that quenching with acetone only has a
significant effect on the intensity of CdSe cores synthesized at reaction time points of 30s, noting
that a comparison of all the intensity p-values may indicate a the existence of a possible trend for
increased effects as reaction times are shortened.

Table 2.5 Two Sample t-test p-values Corresponding to the Effects of Quenching in Acetone vs.
Air for Three Sets of CdSe Core Synthesis Reactions.

Temp
(°C)

Time
(s)

215
215
225

30
60
60

Samples
Samples CMW Intensity FWHM
in
in Air
p-value p-value p-value
Acetone
3
5
0.36
0.01
0.29
5
5
0.56
0.08
0.14
3
3
0.15
0.94
0.06

2.3.1.3 Temporal Wavelength Shifts in White Fluorescing CdSe Cores
Reaction times for the synthesis of white fluorescing cores that varied between 0 and 15
seconds still produced samples that fluoresced with white light, however, the spectrums of each
sample varied. The more time that passed between injection and extraction the more prominent the
primary peak. Figure 2.8 illustrates this effect using two representative samples of WFCs
synthesized at 0 and 15s. A pattern was observed, but not quantitatively tested, indicating a
possible link between higher temperatures at the time of injection, combined with immediate
removal of small samples and rapid quenching, increasing the presence of the 500nm peaks relative
to the other contributing wavelengths. This qualitatively observed alteration produced a solution
that was a pale grey blue color.
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Comparison of WFC Synthesized at 0 and 15s
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Figure 2.8 Typical fluorescence emission spectra for WFCs synthesized at reaction times of 0 and
15s.

It was found that over time the majority of WFCs shifted in fluorescence from a crisp white
to a neon peach. The transition is quantitatively illustrated by the shift in peak position, shape and
intensity. The fluorescence spectrums taken on the day of synthesis, Figure 2.9, show the two
typical spectrum shapes associated with WFCs: a primary peak at 475nm with a wide rolling tail
from 500 to 700nm (blue to green visible light spectrum range), and a large non-descript series of
wide rounded hills (orange to red visible light spectrum range). The fluorescence spectrum of the
same samples, taken 23 days later and show in Figure 2.10, show a significant increase in the
primary peaks at 475nm, as well as the development of a second peak between 620 and 630nm. It
is the development of this second peak in the range of the visible spectrum associated with red, 620
– 750nm, in addition to the 475nm peak associated with blue and cyan, 450 – 495nm, that produces
the orange appearance of the CdSe solution. The degree of the shift is better illustrated in figure
2.11 where the spectrums for both day 1 and day 23 have been overlapped.
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Figure 2.9 Fluorescence spectra of four different WFC solutions taken on the day of synthesis.
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Figure 2.10 Fluorescence spectra of four different WFC solutions taken 23 days after synthesis.

41

Spectral Shift in White CdSe Cores Over 23 Days
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Figure 2.11 Series of four WFC samples synthesized on 2/8, the fluorescence spectrum taken, and
then taken again 23 days later on 3/2. The initial spectrum of each sample is in a dark color and the
corresponding 23 day time point in a lighter shade of the same color.

2.3.2 Synthesis of ZnS Coated Quantum Dots
2.3.2.1 ZnS Coating Synthesis Temperature Variation
In the first round of trials the effect of the CdSe/ZnS synthesis temperature on CMW, intensity, and
FWHM was investigated by applying a synthesis temperature of 70°C and comparing the results to
those of the standard protocol synthesis temperature of 160°C. A two sample t-test, assuming
unequal variances, was performed using an alpha of 0.05 to determine if there was a statistically
significant difference between the means of the CMW, intensity, and FWHM as a result of the
CdSe/ZnS synthesis temperature. Table 2.6 shows the fluorescence emission values for each
sample with the corresponding averages, standard deviations and p-values given in Table 2.7. A bar
chart showing a direct comparison of the average CMWs, intensities, and FWHMs of each
synthesis temperature are given in Figure 2.12 with the error bars for each bar that of the
42

corresponding standard deviation. The p-values calculated for the CMW and intensity, both 0.004,
support the conclusion that decreasing the CdSe/ZnS synthesis temperature of WFCs from 160°C
to 70°C has a statistically significant difference on the final CMW and intensity values. The
associated p-value of the FWHM, 0.255, indicates that the null hypothesis cannot be rejected; it
supports the conclusion that CdSe/ZnS synthesis temperature does not affect the final FWHM of
WFCs.
Table 2.6 CMW, Intensity, and FWHM Values for WFCs Coated at 70°C and 160°C.
Sample
32512QD.30
32512AC.15
41012wQD.0a
32412QD.15B
32412QD.15A
42812gQD.1a
41012wQD.0b
42612wQD.2a

Temp
(°C)
70
70
70
70
160
160
160
160

CMW
(nm)
522
505
482
515
569
560
550
547

Intensity
(counts)
36000
49000
51000
42000
7400
3600
7300
3000

FWHM
(nm)
32
31
36
34
30
37
39
41

Table 2.7 Averages and Standard Deviations of CMW, Intensities, and FWHMS of WFCs
Coated at 70°C and 160°C.

avg
st. dev.
avg
st. dev.
p-value

Temp
(°C)
70
70
160
160

CMW
(nm)
506
17
557
10
0.004
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Intensity
(counts)
44500
6856
5325
2351
0.004

FWHM
(nm)
33
2
37
5
0.255

Comparison of the Effects of QDs shelled at 70°C and 160°C
600

Arbitrary Units

500
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Intensity (counts)

FWHM (nm)

Figure 2.12 Comparison of the average CMWs, Intensities, and FWHMs of each synthesis
temperature with the error bars for each corresponding to the associated standard deviation.

In the second round of trials the effect of the CdSe/ZnS synthesis temperature on CMW was
investigated by applying a synthesis temperature of 110°C in addition to the standard protocol
synthesis temperature of 160°C. As a result of each sample set only containing 2 samples for each
temperature, only qualitative methods were applied for the assessment of the QD end products
synthesized at 110°C and 160°C. A visual comparison the fluorescence emission produced by the
QDs synthesized at 110°C and 160°C of each sample set, shown in Figure 2.13, was used as a
qualitative assessment as to the effect of each coating temperature. In both sample sets, white and
541nm, it was concluded that lower coating temperatures produced QDs with shorter wavelengths.
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Figure 2.13 Qualitative comparison of ZnS shelling temperatures. Left: white fluorescing starting
CdSe, 0a shelled at 160°C, 0b shelled at 110°C. Right: green fluorescing starting CdSe, 60a shelled
at 160°C, 60b shelled at 110°C.

ZnS coating of CdSe Core Sample 52312AC.0 at 160 and 110°C
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Figure 2.14 Averaged fluorescence spectrum of white fluorescing starting CdSe, 160°C (CMW:
540nm; intensity: 19500 counts; FHWM: 39nm), and 110°C (CMW: 495nm; intensity: 37500
counts; FHWM: 43nm), ZnS shelling temperatures.
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Figure 2.15 Averaged fluorescence spectrum of green fluorescing starting CdSe (CMW: 541nm;
intensity: 5800 counts; FHWM: 44nm, 160°C (CMW: 560nm; intensity: 12900 counts; FHWM:
54nm), and 110°C (CMW: 555nm; intensity: 49000 counts; FHWM: 46nm), ZnS shelling
temperatures.

2.4 Discussion
2.4.1 Synthesis of CdSe Cores
Transference of the dry reagents directly into the 50mL round bottom flask, by-passing the
use of the plastic weigh-boats, was done to reduce the discrepancy between the amount of powder
weighed out and the amount that made it into the flask. The selenium powder had a tendency to
adhere to the plastic and the cadmium oxide powder, as a result of static electricity, tended to
bounce out of the weigh-boat during transferring. It was found that quick and precise movements,
on the part of the chemist, during the transfer of the powders from their regent containers to the
reaction flasks, made using the weigh-boats unnecessary.
During the many CdSe core synthesis procedures Se-TOP precursor solutions of different
ages, ranging from 1 to 14 days, were used. After many applications of the different ages of the
Se-TOP precursors, all in conjunction with the use of fresh Cd precursor, it was concluded that Se46

TOP solutions were best used within five days of their synthesis and would consistently give poor
results if used more than 10 days after their initial synthesis. Unlike the Se-TOP precursor, the Cd
precursor returned better results when made in batches no bigger than twice the amount of the
starting values.
2.4.1.1 Experimental Variables Investigated for the General Synthesis of CdSe Cores
A potential method for investigating volume-related effects, in an effort to synthesize CdSe
cores within the 450 -500nm range, would be to implement the use of long thin glass tubing as a
receptacle for which to inject the sample. This tubing could then be submerged in an ice bath
which, along with its reduced diameter, would increase the rate of heat extraction from the sample.
Manipulation of the temperature at the time of the Se-TOP injection was initially thought to be a
possible mechanism for fine-tuning the CMW of the CdSe cores. Although the data would indicate
otherwise, it still may be a parameter to be further investigated for CdSe synthesis involving
reaction time points of longer than 90s. Additionally synthesis temperatures higher than 225°C or
lower than 215°C may show a statistically significant effect on the CMW, intensity, and FWHM of
CdSe cores.
A change in emission wavelength relative to changes in the size of the QD is an inherent
characteristic readily accepted in the synthesis of QDs. Likewise duration of synthesis is related to
QD size and therefore QD emission wavelength. The purpose of testing the effect of different
reaction time points was not to reinvent the wheel, but rather to quantitatively determine the effect
of reaction times of small 30 second increments on CMW, intensity, and FWHM. The data
supported the conclusion that reaction times have a logarithmic effect on the CMW of CdSe cores;
the greatest change in CdSe emission wavelength is seen within the first two minutes. Further
experimentation investigating which variable, reaction temperature or reaction time, is more
influential at longer time points should be explored.
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2.4.1.2 Synthesis of White Fluorescing CdSe Cores
The process for synthesizing of WFCs was stumbled upon while attempting to synthesize
blue QDs. It was reasoned early on in the CdSe core synthesis experiments that if the duration of
the reaction led to CdSe cores of increased diameter, and therefore an increased emission
wavelength, that a reduction in the duration of the reaction would have the opposite effect. The
initial motivation was to produce the ever elusive blue emission wavelength; the result was a range
of wavelengths in s single sample, creating the emission of white light. As a result of the peaks
present in the fluorescence spectrums corresponding to the 15s time points, it is postulated that if a
size selection filtration of the 15s WFCs was employed it may be possible to acquire a solution
consisting of QDs emitting in the 475 – 500nm range in the visible spectrum associated with blue
light.
2.4.1.3 Temporal Wavelength Shifts in White Fluorescing CdSe Cores
The phenomenon of spectral shift frequently seen in the WFCs, and in one case WFCs that
had been ZnS coated and still initially maintained their white emission, appears to be a result of the
lowered synthesis temperature in both the CdSe core and ZnS coating procedures. Although
spectral shifts of ZnS coated WFCs were not measured in the data presented, a visual comparison
of several samples indicated a similar shift. The shift in CdSe cores was seen in samples
synthesized below 215°C; the shift was observed in the WFCs coated with ZnS using synthesis
temperatures below 70°C
2.4.2 Synthesis of ZnS Coated Quantum Dots
Using a standard ratio of 5mL of CdSe core solution to 1mL ZnS precursor for use in every
shelling procedure introduces unknown variability. In Josh Angell’s thesis the ratios chosen were
dependent on the average diameter calculated for the CdSe cores. This same approach was not
applied and therefore may have contributed to the inconsistencies seen in the intensities of the QD
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emission peaks. Although no quantitative data was provided, it was noted during ZnS synthesis
trials that WFC samples tended to show better results using the standard 5 to 1mL CdSe core to
ZnS precursor.
2.4.2.1 ZnS Coating Synthesis Temperature Variation
The purpose for pursuing lower ZnS coating temperatures, such 70°C and 110°C, had been
to test the hypothesis that a gradient of ZnS coating temperatures could be used as an alternative
method for achieving QDs with smaller emission wavelengths shifts. It was discovered that this
was in fact true; lower coating temperatures did result in smaller shifts in CMW. An additional
side-effect, quantitatively supported, was an increase in intensity when these lower ZnS synthesis
temperatures were applied to WFCs. A qualitative assessment of the fluorescence emission spectra
in Figure 2.14 leads to the conclusion that it is very likely that lower ZnS synthesis temperatures
may affect all CdSe solutions in the same way; lowering their shift in CMW and increasing their
intensity.
A straight forward, albeit generic method, that could be employed in future experiments,
with respect to CdSe to ZnS ratios during the shelling process, would be to adjust only the amount
of ZnS precursor injected for each sample of CdSe core. Applying this approach to several
samples, categorizing the CdSe cores based on their emission wavelength, would be a first step in
experimental determining the relationship between CdSe and ZnS ratios. An additional approach
would be to use WFC as the initial sample and apply the primary parameter, reaction time,
associated with the WFC synthesis procedure as a second variable.
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CHAPTER 3 – Quantum Dot Construct Synthesis
3.1 Introduction
The emission characteristics associated with QDs make them an attractive tool for imaging
in biologic mediums. The tunable quality of the emission wavelengths of QDs, along with their
resistance to photo-bleaching, makes them a valuable device for use as biologic tags over their
organic counterparts. An added benefit to using QDs over organic fluorophores is the wide range of
excitation wavelengths that can be used to excite multiple QDs, making it possible to use a single
source to simultaneously excite a variety of QDs. All of these advantageous qualities however, are
useless for application in biologic mediums if the QDs remain hydrophobic. For QDs to be
available for use in biologic applications they must first be made water soluble. There are multiple
methods for achieving this including bioconjugation, ligand exchange, and polymer wrapping. The
method investigated in this thesis was the encapsulation of the hydrophobic QDs inside of a
hydrophilic phospholipid micelle. Phospholipids were the method of QD encapsulation chosen in
light of the fact that the ultimate goal was to introduce the solubilized QDs into EpiDerm skin
substitutes. The introduction of the QDs would be done by applying methods developed by Russell
et.al. pertaining to the interaction of phospholipids within the skin substitutes. It is hoped that the
following encapsulation method will be applied in future endeavors involving the EpiDerm skin
substitutes.

3.2 Methods
3.2.1 QD Precipitation
After the procedure for coating the CdSe cores in a ZnS shell was completed, the QDs were
left suspended in octadecane. Octadecane (ODE) is a straight chain molecule of the alkane family
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with an 18 carbon backbone. Alkanes are insoluble in polar solvents such as water, PBS, or cell
and tissue culturing media; alkanes are hydrophobic (75). As part of the alkane family of
hydrocarbons, ODE is also hydrophobic. This quality makes it an excellent solvent for the QDs
but a poor solvent for phospholipids. Phospholipids are, however, readily soluble in organic
solvents such as chloroform (76). As such, the QDs needed to be suspended in chloroform before
their introduction to the phospholipids. This was accomplished by precipitation of the QDs out of
the ODE and then resuspension of the QDs into chloroform. The method used for the precipitation
of the QDs was developed by Tommy Garting and utilized centrifugation and ethanol in concert
(77). Ethanol (EtOH) acts as an anti-solvent, a medium in which the QDs are insoluble. This along
with ethanol’s characteristic density of 0.790 g/mL, greater than ODE’s density of 0.777 g/mL,
removed the QDs from the ODE and created a pellet of QDs in the tip of the centrifuge tube (78).
Typically two centrifuge tubes were used, into each were placed 3 mL of CdSe/ZnS QDs
suspended in ODE. If a large QD sample, greater than 6mL, was to be precipitated then the sample
was uniformly distributed across an even number of centrifuge tubes. Previous precipitation
methods used a single tube containing a QD sample that was then balanced in the centrifuge by a
tube containing a volume of water equal in weight to the volume of the QD sample. The
precipitation process consisted of adding to the centrifuge tube containing the QDs, a volume of
EtOH of at least 3 mL, but no more than twice that relative to the volume of the QD contents. The
addition of the EtOH caused the contents of the tube to develop an oil-in-water appearance as a
result of the immiscibility of the ODE and the EthOH; Figure 3.1A illustrates this condition. After
addition of the ethanol the centrifuge tube was capped and shaken. The solution was centrifuged
for a length of 10 minutes at a rate of 4000 RPM. After centrifugation the supernatant was
removed. Removal of the supernatant was done using a 3mL syringe and needle and removing the
uppermost portion first. A method of removal working from the top down was performed to ensure
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the complete removal of the ODE. As a result of ODE having a lower density than EtOH, it would
inevitably remain in the top layer of the supernatant. Removal of the supernatant from the lower
portion of the liquid results in a residue of ODE being left behind and greatly hinders the complete
evaporation and quality of the precipitate. Repeated addition of ethanol, centrifugation, and
removal of the subsequent QD-free supernatant with a 3mL syringe, resulted in the eventual
isolation of the QDs in the tip of the centrifuge tube as shown in Figure 3.1B. Each volume of
removed supernatant was expelled into the same waste vial. The vial was then held up to a black
light to determine if any QDs had been inadvertently removed as shown in Figure 3.1C. If the vial
was positive for the presence of QDs, the waste solution was divided equally into centrifuge tubes
and spun down for a secondary precipitation of the QDs. Once the QDs appeared to be firmly set in
the tip of the tube, the tubes were inverted and the viscosity of the QD precipitate was used as a
qualitative assessment as to the successful removal of all ODE. If there was any movement of the
precipitate out of the tip of the centrifuge tube, an additional set of the previously cited
precipitation steps was conducted. After isolation, the centrifuge tubes containing the precipitated
QDs were left in the fume hood for a minimum of 24 hours to ensure that the QD precipitate was
dry and free from any residual solvent before their re-suspension in chloroform. Occasionally a
black precipitate would form in the tip of the tube. This black precipitate was carefully removed.
The entire step by step protocol for the precipitation of QDs out of ODE is given in Appendix B.4.
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Figure 3.1 A visual representation of the steps involved in precipitation: A – QDs in ODE with
EtOH added; B – precipitated QDs with supernatant; C – QDs in supernatant waste;
D–
precipitated QDs; E – precipitated QDs under black light; F- black precipitate.

3.2.2 QD Suspension into CHCl3
After the QD precipitate had a minimum of 24 hours in the fume hood the QD precipitate
was inspected for consistency of color. Occasionally a small particle of black precipitate was
detected in the tip. This black particulate was attributed to precipitation of selenium out of the core
CdSe composite. Into each centrifuge tube 1.5mL of chloroform was added. This resulted in a total
of 3mL of suspended QDs. The suspension was then visually inspected for signs of saturation. If
saturation was apparent, QDs were precipitating out of the chloroform, an additional amount of
chloroform was added in increments of 0.5 mL until a consistent solution of suspended QDs was
achieved.
3.2.3 Phospholipid Concentration, Suspension, and Encapsulation
3.2.3.1 Experimental Trials – Round One and Two
Multiple steps were involved in creating phospholipid encapsulated QDs that could be
suspended in an aqueous media. The course of action taken was to determine an appropriate
phospholipid concentration, an optimal phospholipid to QD ratio, and a successful method of
evaporation that would remove the solvent and suspend the phospholipid encapsulated QDs into
the aqueous media. The saturation tolerance for dissolving phospholipids in chloroform is much
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higher than the saturation tolerance of PBS or keratinocyte media. This fact had to be taken into
account when choosing a PL to solvent ratio in the initial step that would yield the desired PL
concentration. The appropriate PL to solvent ratio was determined by designing a series of
experiments that tested the effects of all of the parameters involved in the encapsulationevaporation process on raising or lowering the saturation points of the PL in each solvent. The
solvent, PL concentration within the solvent, ratio of PL to QDs, ratio of suspended PL/QDs with
respect to the solution they were to be evaporated into, the application of heat to the mixture,
enclosing the reaction, and the use of agitating the mixture were all tested. A sample arrangement
of the parameters tested, using 2.5 mg/mL as the PL concentration, is given in Table 3.1. This
arrangement of tests was duplicated using the additional concentrations of PL in solvent of 1, 5,
and 10 mg/mL.
Table 3.1 PL Concentration and Ratio Test Parameters Applied with 2.5mg/mL Trial
Trial

PL/solvent
(mg/mL)

solvent

A
A
A
B
B
B
C
C
C
D
D
D

2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5

PBS
PBS
PBS
CHCl3
CHCl3
CHCl3
CHCl3
CHCl3
CHCl3
CHCl3
CHCl3
CHCl3

QD/CHCl3 PL/CHCl3
(mL)
(mL)
1
1
1
1
1
1
1
1
1
1
1
1

3
2
1
3
2
1
3
2
1
3
2
1

During the initial test trials each variation of the solutions containing phospholipids were
investigated for possible contributions of the phospholipids to the fluorescence spectrum as a result
of auto-fluorescence. Solutions of phospholipids at multiple concentrations and in multiple
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solvents, such as CHCl3, CHCl3:MeOH, keratinocyte media at different filtration levels, and PBS
were investigated. Additionally the fluorescence spectrums of QDs, before and after the
introduction of the phospholipids, were also generated as a method for assessing the effect that the
phospholipids had on the CMW and FWHM of the test solutions.
Four arrangements of the evaporation test parameters were then designed using each of the
three different ratios of QDs to PLs. with a PL concentration of 2.5mg/mL as shown in Table
3.2.The four different sets of evaporation steps were labeled A, B, C, and D. Set A used 10mL of a
2.5mg/mL solution of PL/PBS in a 1:1, 1:2, and 1:3 ratio of QD/CHCl3: PL/PBS, evaporated
during heating at 60°C. Set B used 10mL of a 2.5mg/mL solution of PL/CHCl3 in a 1:1, 1:2, and
1:3 ratio of QD/CHCl3: PL/PBS, added 2mL of PBS, and then evaporated during heating at 60°C.
Set C used the same concentrations and ratios as set B, but attempted to evaporate the CHCl3 first,
then add 2mL PBS and heat at 60°C. Set D also used the same concentrations and ratios as set B,
but added the 2mL of PBS and attempted to evaporate without heat employing only the air current
generated inside the fume hood.
Table 3.2 PL Encapsulation and Evaporation Parameters
Trial
A
B
C
D

Evaporation during heating at 60°C
Add 2mL PBS, evaporation during heating at 60°C
Evaporate, add 2mL PBS, heat at 60°C
Add 2mL PBS, evaporation, NO heat

During this time a series of slides were prepared using samples with a variety of QD/PL
concentrations that had been suspended in CHCl3:MeOH, then had 2mL of PBS added, heated for a
period of 10 minutes at 55C, and then left to evaporate in the hood for 2 days. These slides were
then imaged with a confocal microscope, using filter Qdot565, and the images for each
concentration qualitatively analyzed.
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A second round of trials was employed specifically to investigate methods for increasing
the rate of evaporation of the chloroform and promoting the suspension of the phospholipid
encapsulated QDs (QD constructs) into an aqueous media. Among the multiple strategies
investigated were the application of nitrogen gas, a magnetic spine vane, closed vials with vent
needles versus open vials, and the size of the evaporation container. In all of these tests the vials
were exposed to heat by being submerged in a 55°C silicon oil bath. Nitrogen gas was applied to
test two methods for increasing the evaporation rate: agitation and increased flow over the surface
of the solution. The nitrogen needle was placed both below the surface of the solution and 1 cm
above the surface with a flow rate high enough to disturb the solution but not eject it out of the vial.
A magnetic spin vane was placed inside of the solution and set to spin at 300 RPM in an effort to
expose the higher density chloroform to air flow as well as to continually mix the solution,
maintaining an even distribution of QD constructs. As a result of the long duration necessary to
achieve of evaporation seen in the first round of encapsulation trials, capping the vials with rubber
septums into which vent needles were placed, as shown in Figure 3.3, was investigated. This
method employed to promote evaporation of the CHCl3 by increasing the pressure in the vial while
maintaining a consistent temperature and reducing the evaporation of the PBS.
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Figure 3.2 Arrangement of three vials containing QD construct solutions with rubber septums and
vent needles.

Increasing the size of the evaporation container, to increase the size of the surface area exposed to
air flow, was accomplished by placing the test solution into a 50mL glass beaker with a 5cm
diameter. The discovery in chapter 2, of CHCl3 degrading the plastic cuvettes, was used as an
initial determination for the presence of CHCl3 within the evaporating test solution. Although use
of the cuvette could not definitively determine the absence of chloroform, placing a cuvette into the
solution of interest, and noting its appearance 5 minutes after exposure, could positively confirm
the continued presence of chloroform.
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3.2.3.2 Final Encapsulation Method
The final protocol for the phospholipid encapsulation of QDs, and their suspension into an
aqueous media via evaporation, was developed by incorporating the factors that were deemed
successful from the initial round of trials. These factors were then altered to accommodate the
desired PL/keratinocyte media concentration of 10mg/mL or 1.0 % w/v that was used in the
Russell et. al. paper. The first step was choosing a CdSe/ZnS sample, created using the process
described in chapter 2, which had an appropriate CMW and FWHM for imaging with fluorescent
stains without overlap of the emission spectrums. For round one (R1) of the keratinocyte trials the
CdSe/ZnS QD chosen was 42612wQD.2a with a CMW of 551nm and FWHM of 42nm, which
provided an emission that fell between the wavelengths emitted by the Calcein and EthD-1
fluorescent stains used for testing cell viability: 515 and 635nm respectively. The 10mL QD
sample was divided evenly into four centrifuge tubes, 2.5mL into each tube. Each tube then
received 5mL of EtOH, was placed into the centrifuge, and spun at 4000 RPM for 10 minutes.
After centrifugation the supernatant was removed from each tube, working from the top of
the liquid down. Another 5mL of EtOH was added to each tube and a second centrifugation at 4000
RPM for 10 minutes was performed. The tubes were then inverted and the supernatant poured out
leaving the precipitated QDs in the tip of each tube. All four uncapped tubes were placed
horizontally in the fume hood with their open ends pointed toward the fume hood door for
maximum exposure to air flow. Fourteen hours later the dry tubes were determined to be dry.
After being removed from the fume hood, 1.25mL of CHCl3 was added to each tube for a
total of 5mL of QD suspended in CHCl3. A PL/CHCl3 solution with a concentration of 10mg/mL
was made by dissolving 100mg of milk phospholipid powder (Phospholipid Concentration 700,
Finterra Ltd, Edgercumbe) into 10mL of CHCl3. The amount of 10mg/mL PL/CHCl3 to be made
was dependent on the amount of keratinocyte media into which it would be evaporated: 10mL.
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Using an amount of PL/CHCl3 equal to the amount of keratinocyte media maintained the desired
10mg/mL concentration in the final product. Together this combination created a final ratio of 1mL
of QD/CHCl3 for every 20mg of PL. In the past test trials a 1: 2 ratio of QD/CHCl3: PL/CHCL3
[2.5mg/mL] was used resulting in a final ratio of 1mL of QD/CHCl3 for every 5mg of PL. To
maintain this past ratio it would have been necessary to have added 20mL of QD/CHCl3. The 5mL
of QD/CHCl3 and 10mL of 10mg/mL PL/CHCl3 were combined in a 50mL glass beaker. Added to
this was 10mL of keratinocyte media. A magnetic spin vane, 2.5cm in length, was place into the
beaker with the mixture. The beaker was then placed at an angle into a silicon oil bath set at 50°C
and 200 RPM. The beaker was removed twenty two minutes after being placed into the silicon oil
bath.
UV-VIS spectroscopy was used to determine the influence of the encapsulation process on
the center max wavelength (CMW), FWHM, and intensity of each QD sample used in the
encapsulation. This progression of shifts in the characterization parameters provided a quantitative
method for analyzing and predicting final wavelength and intensity measurements. Starting with
the CMW, FWHM, and intensity of the CdSe core sample, and continuing to record the same
characterization parameters of the CdSe/ZnS QD sample in ODE, the CdSe/ZnS QD sample in
CHCl3, the QD:PL:CHCl3, and the final encapsulated QD:PL construct, provided a linear
progression of the shifts in the characterization parameters as a direct consequence of each step in
the encapsulation procedure. Additional UV-VIS spectrometer data, of control samples, were
utilized to determine the influence of the components specific to each step on the characterization
parameters. These same UV-VIS characterization parameters were applied to samples of CHCl3,
PBS, and variety of PL concentrations in CHCl3 and PBS, all of which added an additional
dimension of understanding as to the influence of each step on the final CMW, FWHM, and
intensity outcomes.
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3.3 Results
3.3.1 QD Precipitation
Complete precipitation of the QDs out of ODE was determined based on a qualitative
assessment of the centrifuge tubes. The conclusions resulting from the examination of the texture,
transparency, and viscosity of the centrifuged QDs dictated the success of the precipitation and
whether an additional round of centrifugation was needed. After the first centrifugation the
QD/ODE/EtOH solution in the tube had the appearance of image A in Figure 3.4; the majority of
the QDs toward the bottom of the tube but still not precipitated into a solid pellet at the tip. After
removal of the supernatant, the addition of an equal amount of EtOH and vigorous shaking of the
capped tube redistributed the QDs throughout the solution as shown in images B and C of Figure
3.3.

Figure 3.3 QDs suspension in ODE and EtOH after the first series of centrifugation steps. A – after
the first centrifugation, before the removal of the supernatant. B – after the addition of EtOH with
vigorous shaking in white light. C - after the addition of EtOH with vigorous shaking in UV.

3.3.2 QD Suspension into CHCl3
In instances where saturation was apparent, QDs were precipitating out of the chloroform as
shown in Figure 3.4, an additional amount of chloroform was added in increments of 0.5 mL until a
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consistent solution of suspended QDs was achieved. It was not always immediately apparent that
the chloroform was saturated. On average the final solution was 3mL in total.

Figure 3.4 A – Re-suspension of QDs in CHCl3. B – Saturation of QDs re-suspended in CHCl3.

3.3.3 Phospholipid Concentration, Suspension, and Encapsulation
3.3.3.1 Experimental Trials – Round One and Two
The saturation point of phospholipids in PBS and keratinocyte media was determined to be
10mg/mL with the application of heating the mixture to 52° and vigorous agitation by shaking the
capped vial. The saturation point of phospholipids in chloroform was not ultimately determined,
but as the chloroform continued to dissolve an amount of 35mg/mL, more than three times that of
the aqueous mediums, further dilutions were not deemed necessary.
Table 3.3 Comparison of QD samples in CHCl3 and QD/PL samples in CHCl3
Sample
31912QD1.M45m
31912QD1.M45s
31912EN1.M45m
31912EN1.M45s

Solvent
CHCl3
CHCl3
CHCl3
CHCl3

CMW
(nm)
583
586
575
577

Intensity
(counts)
48000
47000
56000
45000
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FWHM
range (nm)
571-598
574-599
556-590
560-592

FWHM
(nm)
27
25
34
32

Figure 3.5 A representative image of 0.45 micron filtered 10mg.mL PL/keratinocyte media
solution scattering the UV source in the fluorescence detector.

Possible phospholipid related auto-fluorescence issues were investigated with respect to the
wavelength at which auto-fluorescence might have occurred. It was concluded that when combined
with QDs in CHCl3 the emission of the PL solutions were negligible in range of the QD
wavelength of interest. Therefore, although auto-fluorescence was confirmed quantitatively by UVVIS spectroscopy, its influence on the ability to detect the presence of the encapsulated quantum
dots was deemed negligible. Fluorescence spectra characteristic of solutions containing
phospholipids exhibited dominating peaks at the wavelength of the emission source: 388nm. Peaks
at 500 and 660nm were also routinely detected. The size and intensity of each peak was influenced
by the solvent in which the PL was dissolved.
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Figure 3.6 Fluorescence spectra of phospholipids at different concentrations, in different medias
taken at an integration time of 100ms; the source peak from scattering occurring at 388nm.
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Figure 3.7 Fluorescence spectra of phospholipids at different concentrations, in different medias
taken at an integration time of 500ms; the source peak from scattering occurring at 388nm.
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For better visualization, the relative size of the fluorescence emission peaks for the solutions with
QD constructs and those with only phospholipids the horizontal axis was decreased to only include
a range of 450 to 650nm. It was this range of wavelengths that was pertinent to determining if the
auto-fluorescence emission of the phospholipid solutions made a significant contribution to the QD
construct emission peaks. It was concluded that the contribution of the phospholipids to the final
emission peak of the QD constructs was negligible. Figure 3.9 shows a representative example of
the two solutions in direct comparison.

Intensity (counts)

42612wEN.2a Phospholipid Encapsulation Progression
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18000
16000
14000
12000
10000
8000
6000
4000
2000
0

PL/krt [10mg/mL] - 0.45 micron filter
PL/krt [10mg/mL] - 0.2 micron filter
42612wEN.2a/krt - 0.45 micron filter
42612wEN.2a/krt - not filtered
450

500

550

600

650

Wavelength (nm)

Figure 3.8 Fluorescence spectra of the 0.45 and 0.2 micron filtered [10mg/mL] PL/keratinocyte
solutions relative to QD/PL/keratinocyte solutions.

An initial evaporation test was performed on solutions of varying concentrations of QD/PL/
CHCl3:MeOH and PBS. This initial test was conducted using a minimal application of heat, 10
minutes at 55°, and an extended evaporation time, 2 days, to determine if evaporation alone would
produce a final QD construct product using a technique similar to the one described in the Carion
et.al. paper. The series of steps was documented and the corresponding images are given in Figures
3.9, 10, and 11. Figure 3.10 shows the solutions after the addition of PBS and 30 minutes of
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vigorous shaking. The final volume of each test solution had decreased at the end of the two day
evaporation period, but a significant proportion of the CHCl3:MeOH remained and still contained
the majority of the QD constructs, with a thin layer of constructs formed in the middle layer as
illustrated in Figure 3.11. This result pointed to the need for a method of internal agitation of the
solution to be introduced.

Figure 3.9 Different concentrations of PL [(3.3, 3.3, 5.0, 10.0) mg/mL] and QD sample
330QD3.3M45 suspended in CHCl3MeOH. Left: white light. Right: UV.

Figure 3.10 Addition of 2 mL PBS in to each: both in white light and UV. The addition of the PBS
was done before evaporation and heating. PBS created an emulsified appearance. Left: white light.
Right: UV.
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Figure 3.11 After 10min of heating at 55C and 2 days of evaporation in the hood. Left: white light.
Middle: UV. Right: Schematic representation of final solution composition. A- PBS.
B – QD
constructs. C- QD constructs suspended in CHCl3:MeOH.
Confocal microscopy was used to qualitatively assess how the different concentrations of
PL in solvent, and the different ratios of PL to QD in each solution, effected the composition of the
QD constructs. Samples of CHCl3, PBS, and [2.5mg/mL] concentration of PL/PBS were taken as
controls for comparison. The smeared quality of the larger aggregates of phospholipids, figures
3.13, and 3.15 are an effect of the increased concentrations of PL within each solvent, as well as
decreased ratios of QD to PL resulting in less volume of QDs for every milligram of PL, all
resulted in a less uniform and more globular appearance of the QD constructs. Comparison of the
control solutions containing [2.5mg/mL] PL/PBS with the test solution consisting of 2.5mL of
[3.3mg/mL] PL/CHCl3:MeOH and 1.0 mL of 31912QD1.M45m in CHCl3:MeOH shows little
difference between the two. The lack of difference introduces an uncertainty as to the degree to
which the QDs were successfully encapsulated. Successful encapsulation of QDs within the
phospholipid micelles was later confirmed using the fluorescence microscope (images not shown)
and the confocal microscope to image the test solutions in the first round of keratinocyte trials.
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Figure 3.12 Controls: A- [2.5mg/mL] PL/PBS at 20X. B - [2.5mg/mL] PL/PBS at 100X. C –
[2.5mg/mL] PL/CHCl3 at 20X. D – PBS control

Figure 3.13 A solution of 2.5mL of [3.3mg/mL] PL/CHCl3:MeOH and 0.5 mL of the QD sample
31912QD1.M45m. At precipitation 31912QD1.M45m had been re-suspended in 3.0:1.5
CHCl3:MeOH at 20X
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Figure 3.14 A solution of 2.5mL of [3.3mg/mL] PL/CHCl3:MeOH and 1.0 mL of the QD sample
31912QD1.M45m. At precipitation 31912QD1.M45m had been re-suspended in 3.0:1.5
CHCl3:MeOH at 20X.

Figure 3.15 A solution of 3.5mL of [10mg/mL] PL/CHCl3:MeOH and 0.5 mL of the QD
sample 31912QD1.M45s. At precipitation 31912QD1.M45s had been resuspended in 3.0:1.5
CHCl3:MeOH at 20X
In the series of evaporation tests conducted to determine the most successful set of
parameters to employ in the final encapsulation and evaporation procedure, it was found that
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application of the nitrogen below the surface of the solution resulted in the creation of dried out
strings of QD constructs; defeating the goal of acquiring an even distribution of QDs within the
aqueous liquid. Evaporation times in the first round of trials were upwards of 4 hours and it was not
discernible whether the remaining liquid was PBS or chloroform. Capping the glass vials with
septums and adding a vent needle to increase the pressure within the vial decreased the amount of
time that was required to reduce the volume of clear liquid within the vial, but did not answer the
question as to what the identity of the remaining liquid. A preliminary test for determining the
presence of chloroform was to expose a plastic disposable cuvette to the solution in question for a
period of 5 minutes. If the surface of the plastic in contact with the solution degraded, the presence
of chloroform was confirmed. Increasing the diameter of the container used during evaporation
increased the rate of evaporation of CHCl3 when used in concert with a magnetic spin vane set to a
minimum of 200RPM. Applying heat to the solution also increased the rate of evaporation.
A visual representation of the progression of sample D from the first round of encapsulation
tests is given in Figure 3.16. The progression starts with the original sample, 32412QD23.15A,
suspended in CHCl3 with PL shown in white light and UV, through to its appearance after testing
had concluded. The three vials of sample D never individually achieved full evaporation of CHCl3,
however, after combining all three and applying the final encapsulation method the CHCl3 was
fully evaporated and the QD constructs suspended into PBS.
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Figure 3.16 Encapsulation progression of set D. From top to bottom: 32412QD23.15A suspended
in CHCl3 with PL in white light, in UV light, addition of 2mL PBS in white light, in UV light, final
state post-evaporation in white light, and in UV light.

Figure 3.17 Encapsulation progression of sets A, B, C, and D from left to right. Top: white light.
Bottom: UV light.

Figure 3.18 Encapsulation trial 2B. Starting solution of 2mL 2.5mg/mL of PL/CHCl3: 1mL
324QD123.60a in CHCl3: 2mL PBS in an open vial heated at 55°C.
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3.3.3.2 Final Encapsulation Method
The solution of 5mL of QD/CHCl3 and 10mL of 10mg/mL PL/CHCl3 appeared consistent
throughout. The mixture resulting from the addition of the keratinocyte media to the QD/PL/CHCl3
formed two separate layers as illustrated in Figure 3.19. The bottom layer of the mixture is the
higher density QD/PL/CHCl3 solution and the top layer is the lower density aqueous keratinocyte
media. As the image on the left indicates, there is complete separation of the two layers. Over time
the viscosity of the solution thickened until a substance the consistency of yogurt was formed. A
series of images depicting the change in the mixtures appearance and viscosity is given in Figure
3.20. Twenty two minutes after being placed into the silicon oil bath all remaining clear liquid had
been absorbed or evaporated.

Figure 3.19 Pre-evaporation combination of 5mL of QD/CHCl3: 10mL of 10mg/mL PL/CHCl3:
10mL keratinocyte media in white light (left) and UV light (right)
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Figure 3.20 Mid-evaporation of 5mL of QD/CHCl3: 10mL of 10mg/mL PL/CHCl3: 10mL
keratinocyte media at 5, 10, and 15 minutes from left to right.

3.4 Discussion
3.4.1 QD Precipitation
Typically only two rounds of precipitation steps were necessary to achieve a solid
precipitate in the tip of the centrifuge tube; on occasion three rounds. It was discovered through
the many precipitations that if more than three rounds were required, the results of products further
down the line were often less than desirable. For this reason any attempt at precipitation that did
not yield a solid precipitate in the tip of the tube by the third round was discarded unless the QD
sample was of particular importance.
The previous method of precipitation involved placing the entire QD sample in one tube
and using a second tube of water, equal in weight to the QD sample, to act as a balance during
centrifugation, was found to be tedious and overly time consuming. As a result of the 12mL
maximum capacity of each centrifuge tube, handling QD samples of more than 5mL, which would
have required 10mL of EtOH, resulted in 4, 5, and 6 rounds of the precipitation steps to achieve a
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solid precipitate in the tip of the tube. As an antidote to this problem, the multiple centrifuge tube
method was used. Not only did this decrease the time necessary to precipitate the QDs, but multiple
samples, up to six, could be simultaneously centrifuged as long as care was taken to ensure that all
tubes contained equal volumes of mixtures.
With regard to the formation of black precipitates in the tip of the centrifuge tubes, it was
concluded that the black particulate that sometimes formed was selenium. It was determined to be
selenium because of the resemblance of the precipitate to the starting material used in the synthesis;
selenium powder was the only component that was also black. Precipitation of selenium had
occurred for one of two reasons: the initial precipitated sample had been that of unshelled and
therefore unstable CdSe cores, or the initial precipitate was of a shelled sample that had not been
consistently and effectively shelled leading to the same outcome. In carefully and consistently
synthesized CdSe/ZnS QDs the black precipitate was a rare occurrence.

3.4.2 Phospholipid Concentration, Suspension, and Encapsulation
3.4.2.1 Experimental Trials – Round One and Two
Fluorescence spectra of PL in a variety of solvents showed both an element of autofluorescence in the 500 and 660nm peaks as well as scattering of the source at 388nm. The peak
from the source was so large as to be larger than what the spectrum would accommodate, however,
this peak was only significant when the solvent was either PBS or keratinocyte media or contained
MeOH. The solutions consisting of only PL and CHCl3, no matter the concentration of PL, had a
relatively insignificant peak at 388nm.
Confocal microscope images obtained using the Qdot565 filter were used as a qualitative
assessment of the encapsulation process for different concentrations of PL in solvent and different
ratios of PL to QD. The images of the control solutions support the conclusion that the PLs have a
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greater affinity for aggregating together as micelles and liposomes when suspended in an aqueous
solution. The controls also eliminate the possibility that the solvents are introducing any
particulates. The confocal images in Figures 3.13, 14, and 15 support the conclusion that solutions
with smaller concentrations of PL and a more equal ratio of PL to QD produce more consistently
sized and spherical QD constructs. The conclusions made as a result of the initial PL concentration
tests would have been used in the final method if not for the desire to achieve a 10mg/mL
concentration of QD constructs in keratinocyte solution for mimicking the media parameters
described in the Russell et al. paper.
The greatest difficulties encountered in the encapsulation process were consistent and
complete evaporation of the chloroform in a timely manner, and the consistency of the final QD
construct aqueous solution. Without exposure to the air it was not possible to remove the
chloroform form the mixture via evaporation. This particular difficulty, the evaporation of the
CHCL3, was the catalyst for the development of so many evaporation strategies. The densities of
each element had a significant effect on the development and success of the procedure. The
solubility of chloroform in water is g/100mL at 20°C: 0.8 making chloroform essentially
immiscible in water (79). The density of chloroform relative to water is 1.48:1.0 (kg/m3) at 20°C.
When the two solvents were mixed, this attribute caused chloroform to sink to the bottom and for
the water, PBS, or keratinocyte media to float to the top; water and PBS have equivalent solubility
and density characteristics relative to chloroform (79). The immiscibility of chloroform in water
based solvents, coupled with chloroforms’ density prevented the QD:PL constructs from achieving
suspension in the upper layer.
The three main literature references used in the initial phases of developing the
encapsulation method laid out in this thesis were Fan et.al., Carion et. al., and Dubertret et. al. (1113). The Fan et. al. paper proposed encapsulation by the introduction of the QD/CHCl3 suspension
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to an aqueous lipid solution with the application of vigourous stirring to create a micro-emulsion
that was then to be heated between 40 and 80°C for approximately ten minutes to evaporate off the
chloroform and transfer the QDs into the aqueous solution. The Dubertret et. al. paper used “a
mixture of n-poly(ethylene glycol) phosphatidylethanolamine (PEG-PE) and phosphatidylcholine
(PC) and did not explicitly state there method for encapsulation. The only indication for what
process was used to achieve encapsulation was a diagram indicating that after being combined the
QD/PL solution was evaporated, heated, and then water was added. This was less than helpful and
all of my tests that applied evaporation and heating before adding the aqueous medium did not
yield successful results. The Carion et. al. paper was thorough and explicitly detailed each step
used in their process. It was by far the best source available in the literature. The procedure
outlined in the Carion paper was quoted as taking 6 hours and utilized equipment and ingredients
not available at the time of the work for this thesis. It would, however, be a worthwhile method to
investigate for the future.
3.4.2.2 Final Encapsulation Method
The deviation of the final encapsulation method, with respect to the ratio of milliliters of
QD/CHCl3 to milligrams of PL, from the test trials was a result of trying to duplicate the
concentration of PL in keratinocyte media that was used in the Russell et al. paper. Ultimately, the
goal was to introduce the QD constructs into EpiDerm skin substitutes. For this reason using a
solution that mimicked the original 1% w/v phospholipid/keratinocyte media, like that which had
been used in the Russell experiments, would eliminate the one variable in the effect of the QD
constructs on the skin substitutes. It was, however, noticed that compared to the original tests,
which had optimum results using a ratio of 1mL of QD/CHCl3 for every 5mg of PL, and 2mL
aqueous media for every 1mL of QD/PL/CHCl3, the final method employed tended to create a
more coagulated product, which 66% of the time resulted in difficulty during filtering. The
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difficulty in filtering stemmed from an increase in the viscosity and uneven distribution of the QD
constructs throughout the aqueous media. Overall, the final encapsulation method is a process that
from start to finish can be accomplished in approximately 3.5 hours.
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Chapter 4 - Introducing Quantum Dot Constructs into a Biologic Medium
4.1 Introduction
Upon achieving successful encapsulation of the CdSe/ZnS QDs within phospholipid
micelles, and evaporating them into an aqueous media, the next step was to introduce the QD
construct solution into a biologic medium. The biologic mediums chosen for this purpose was
keratinocyte cell cultures. Introduction of the QD constructs into keratinocyte cell cultures was
performed to assess two parameters of QD-cell interaction: QD-cell integration and cell health
post-introduction of QD construct solutions. The success of QD-cell integration was qualitatively
assessed using the ratio of the number of cells with QD constructs attached to their cellular
membranes relative to the number of cells without any QD constructs attached to their membranes.
In addition to attachment of QD constructs to the exterior of cell membranes, the degree of
integration into the keratinocyte cells was also assessed. The effect of the QD constructs on cell
health, post-introduction of the test solutions, was measured by a comparison of cell viability,
proliferation, and morphology from before and after the introduction of the QD constructs test
solutions.
Evaluation of the effects of QD-construct solutions on the health of the keratinocyte cells
was done using imaging and histology techniques. An optical white light Olympus CKX41
microscope was employed for the comparison of changes in cell morphology and culture
appearance and used as a qualitative assessment of the effects of QD construct solutions on cell
health. Calcein and Ethidium homodimer-1 (EthD-1) live dead (L/D) stains were used in concert
with confocal and DIC imaging to determine the percentage of live to dead cells within each fourwell chamber. QD construct adherence to, and integration within, keratinocyte cells was done by
qualitative inspection of confocal and DIC images. Histochoice fixative and Hoechst stain (H/H)
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were used to identify the nucleus of each cell, thereby making it possible to accurately differentiate
QD constructs exterior to the cell membrane surface relative to QD constructs interior of the cell
membrane surface. Application of the Hoechst stain also allowed for distinguishing the
keratinocyte cells relative to any unwanted contamination sources, such as spores, molds, or fungus
that may have been present and which the QD constructs may have also interacted with.

4.2 Methods
4.2.1 QD Construct Introduction into Keratinocytes Cell Cultures
The cells to which the QD construct test solutions were applied were Primary Epidermal
Keratinocytes; normal (non-diseased), human, from neonatal foreskin; supplied by ATCC, product
number PCS-200-010. The media for the keratinocytes, also supplied by ATCC, was a base
solution of dermal cell basal medium with keratinocyte growth kit. The keratinocyte growth kit,
product number PCS-200-010, included 2 ml of bovine pituitary extract, 0.5 ml rh TGF-alpha, 15
ml L-glutamine, 0.5 ml hydrocortisone hemisuccinate, 0.5 ml rh insulin, 0.5 ml epinephrine and 0.5
ml apo-transferin. The cells were thawed from cryopreservation and passed into T75 flasks. The
cells were incubated at 37°C, 5% CO2, and 95% humidity in the primary incubator, and given
fresh media every 36 -48 hours (80). All cell culture handling and maintenance, pre-introduction of
test solutions, was conducted by Carl T. Dargitz.
A maximum time point of 24 hours was chosen for the keratinocyte QD construct
experiments as a consequence of the realities associated the maintenance of an aseptic culture
environment for the duration of the keratinocyte related trials. The uncertainty for maintaining an
aseptic environment stemmed from three different factors: the design of the four-well flasks,
working outside of the laminar flow hood, and using the secondary not aseptically maintained dry
incubator for incubation post-introduction of the test solutions. Unlike the T75 culture flasks that
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the cells were initially grown in, the four-well slides are not sealable with a filter-cap. This factor
increases the likelihood that any environmental contaminants that may be present will likely invade
the culture and affect the viability of the cells. To combat the constraints of working in a nonaseptic environment, handling of the keratinocyte cultures was done wearing nitrile gloves sprayed
down with 70% isopropyl alcohol (IPA). All surfaces, counter-tops, the incubator shelves and
door, and the optical microscope stage platform, which the four-well slides containing the
keratinocyte cultures came in contact with, were also sprayed down with 70% IPA and air dried
before any contact was initiated. This in no way ensured that contamination of the cultures would
be prevented. However, this precaution, along with the short time point of 24 hour postintroduction of testing of solutions, prevented contamination from reaching levels that would
detrimentally affect the experimental parameters of interest.
4.2.1.1 QD Construct Control and Test Solutions – R1
In the first round (R1) of test solutions an extensive set of control solutions were employed
in an effort to identify the influence of non-QD construct specific variables on the viability of the
keratinocyte cells. Each step involved in the process of developing the final QD construct test
solutions contributed variables, which if untested, would introduce sources of unknown influence
and variability on the cell health and cell-QD construct interaction of the final product. The test
solutions and test parameters, related to the variables associated with the QD construct solution
development process, that were investigated in the first round of keratinocyte experiments are
given in Table 4.1. Figure 4.1 shows representative images of the four-well slides, each containing
four culture chambers, used in R1 and R2.
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Figure 4.1 Representations of four-well slide configurations. A. All six four-well slides used in R1
of keratinocyte trials. B. Schematic diagram of four-well slide without thick specimen slide base.
C. Four-well slides used in R2. D. Schematic diagram of four-well slide with thick specimen slide
base.

Each well-set used in the first round of the keratinocyte trials, a and b, had three four-well
slides for a total of 12 wells in each set. Within each set, a and b, were three sub-sets, one for each
slide. Slide one of set a contained wells a1.1-4, slide two contained wells a2.5-8, and slide 3
contained wells a3.9-12. This same labeling was applied to well-set b. Table 4.1 shows the test
solutions corresponding to each well, the size of the filter that may have been used to filter the test
solutions, and the fluorescent stain applied each well. The designation L/D represents the live/dead
stain, which was composed of Calcein and Ethidium homodimer-1. The first round of keratinocyte
trial test solutions were created primarily to determine the extent to which each step in the QD
construct synthesis process affected cell health. Heating the keratinocyte media to 55°C, exposure
of the keratinocyte media to chloroform during evaporation, the presence and size of phospholipid
particulates, and filtering to reduce contamination were all variables that could affect change on
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cell viability and proliferation. Therefore, each well was filled with a test solution that
corresponded to the variable in question.
Table 4.1 Summary of Round One QD Construct Control and Test Solutions
Well

Test Solution

a, b1.1
a, b1.2
a, b1.3
a, b1.4
a, b2.5
a, b2.6
a, b2.7
a, b2.8
a, b3.9
a, b3.10
a, b3.11
a, b3.12

Control - krt media
Control - krt media
Control - krt media post-CHCl3
Control - krt media/PL post-CHCl3
PL/krt [10mg/mL]
PL/krt [10mg/mL]
PL/krt [10mg/mL]
PL/krt [10mg/mL]
42612wEN.2a: PL/krt [10mg/mL]
42612wEN.2a: PL/krt [10mg/mL]
42612wEN.2a: PL/krt [10mg/mL]
42612wEN.2a: PL/krt [10mg/mL]

Heated
55°C
X
X
X
X
X
X
X
X
X
X
X

Filter

0.45µm
0.45µm

0.45µm
0.45µm

Stain
L/D
L/D
L/D
L/D
L/D
L/D
L/D
L/D
L/D
L/D
L/D
L/D

Four variations of keratinocyte media, applied to wells a, b1.1-1.4, were used as a set of
controls. Wells a,b1.1 were used as a primary control and wells a,b1.2-4 were used as secondary
controls. The secondary controls were compared with the primary control, as well as with the
unadulterated keratinocyte media, to determine the influence of the heat, chloroform exposure, and
the presence of phospholipids on the media’s ability to function in the expected capacity of cell
maintenance. The results of the primary control, as well as that of the secondary controls, were
used as a baseline for cell viability. The controls were used as a standard of comparison during
assessment of wells a, b2.5-8 and a, b3.9-12, both of which contained additional components.
After attending to the issue of which effects, related to alterations of the keratinocyte media
during the QD construct synthesis process, had an influence on cell viability, two additional
elements needed to be addressed with respect to the test solutions: particle size and culture
contamination. In wells a,b2.5-8, containing only phospholipids in media, the questions
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investigated pertained to what role the size of the particles played in the interaction between the
constructs and the cells and what degree of contamination could the test solutions introduce into the
cell cultures. It was important to determine if the presence of phospholipids alone had a negative
effect on the cells’ viability and if so, was it merely because they introduced some phospholipidspecific factor into the environment or were the negative effects the result of the phospholipids
directly interacting with the cells. A 0.45µm filter was used to acquire these answers. Filtering
was also applied to two of the four solutions containing the phospholipid encapsulated QDs.
Filtering of the QD construct solutions was not only done for the previously stated reasons, but also
to determine the effect of filtering on the CMW, intensity, and FWHM of the fluorescence
emission of the solution.
The initial CdSe core sample, 42612wCMBO.2, used in the first step for creating the QD
construct test solutions, was a combination of five previously synthesized CdSe core samples that
had originally been synthesized using the modified protocol in Chapter 2. A ZnS coating was
applied to this combination sample using a shelling temperature of 160°C and producing the
CdSe/ZnS QD sample labeled 42612wQD.2a. The encapsulation process documented in Chapter 3
was then applied to the newly shelled sample to create the hydrophilic QD constructs and transfer
them into the keratinocyte media. After encapsulation the QD construct, the solution was passed
through a 0.45 micron filter to aid in removal of any contaminants present within the solution, as
well as to remove any excess phospholipids that had failed to form a micelle around the QDs. At
each step during the QD construct synthesis a fluorescence spectra was taken using the Ocean
Optics USB 4000 fiber optic spectrometer to track the changes in CMW, intensity, FWHM, and
scattering resulting from the processes and materials of each step.
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Figure 4.2 Progression of the 42612wQD.2a used in the test solutions in the first round of
keratinocyte QD construct trials. A. The five individual CdSe composite cores. B.The five
combined CdSe cores. C. The combined CdSe cores shelled with ZnS at 160°C (550nm: 2800
counts)
4.2.1.2 QD Construct Control and Test Solutions – R2
Round two of the test solution experiments concentrated on assessing the effects of added
filtering with 0.2 micron diameter pore filters, as well as using additional staining techniques to
assess cell viability and cell-QD construct interaction. Additional filtering, using a 0.2µm filter,
was imposed to investigate the benefits of using a more rigorous filtering regime. The expected
benefits of using a smaller filter were a decreased incidence of contaminating components within
the solution and size selection of the QD constructs suspended in solution. Decreasing the
contaminants within the solution would prevent the growth of non-cellular components within the
culture. Reducing the size of the QD constructs could promote the attachment and integration of
the constructs to the keratinocyte cells. The test solutions, the filters employed, and the stains
applied to each well-set are given in Table 4.2. Like the test solutions used in R1, the well
designations indicate each four-well slide and each sub-set of wells. In the second round of
keratinocyte trials a second staining technique, Histochoice and Hoechst, was employed for
additional assessment of cell presence and proliferation. Two different QD constructs were used in
the test solutions: 52312EN45.60b and 42612oEN.1a.
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Table 4.2 Summary of Round Two QD Construct Control and Test Solutions
Well
a, b, c1.1
a, b, c1.2
a, b, c1.3
a, b, c1.4
a, b, c2.5
a, b, c2.6
a, b, c2.7
a, b, c2.8

Test Solution

Filter

Control - krt media
42612oEN.1a: PL/krt [10mg/mL]
PL/krt
[10mg/mL]
52312EN45.60b: PL/krt [10mg/mL]
42612oEN.1a: PL/krt [10mg/mL]
Control - krt media
52312EN45.60b: PL/krt [10mg/mL]
PL/krt
[10mg/mL]

0.2µm
0.2µm
0.2µm
0.45µm
0.45µm
0.45µm

Stain
(a)
H/H
H/H
H/H
H/H
L/D
L/D
L/D
L/D

Stain
(b)
L/D
L/D
L/D
L/D
H/H
H/H
H/H
H/H

Stain
(c)
H/H
H/H
H/H
H/H
L/D
L/D
L/D
L/D

Two different QD construct samples were used as test solutions: 42612oEN.1a and
52312EN45.60b. The original CdSe core sample used to synthesize 42612oEN.1a was composed
of four previous CdSe samples: 102511W2.10, 12611AC.30, 2812ARC.1A, and 2812ARC.1B0.
This new combination sample, 42612oCMBO.1, had been shelled with a ZnS coating at 160°C,
encapsulated in a 10mg/mL PL/CHCl3 solution, and evaporated into keratinocyte media using the
protocol from Chapter 3.

Figure 4.3 Progression of the 42612oEN.1a used in the test solutions of R2 trials. A. The four
individual CdSe composite cores. B. The four combined CdSe cores. C. The combined CdSe cores
shelled with ZnS at 160°C (537nm:7400counts: FWHM 40).
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The original CdSe core sample used to synthesize 52312EN45.60b was a combination of
two previous CdSe samples, 52312AC4.60 and 52312AC5.60, both which were synthesized at
225°, combined, shelled with a ZnS coating at 110°C, encapsulated in a 10mg/mL PL/CHCl3
solution, and evaporated into keratinocyte media using the protocol from Chapter 3. The choice of
each CdSe/ZnS sample to be used in the synthesis of the QD construct test solutions was made
based on the CMW and FWHM of each sample relative to the emission wavelengths associated
with the L/D stains; it was necessary that the emission wavelength of the QD constructs overlap as
little as possible with the L/D stain emission wavelengths. With the CMW of the emission
wavelengths for Calcein and EthD-1 being 515 and 635nm respectively, it was important to have a
QD emission wavelength that would be intermediate between the two with as little overlap as
possible. The CMW, intensity, and FWHM of 42612oEN.1a and 52312EN45.60b were 537nm:
7400counts: FWHM 40nm and 564nm: 15200counts: FWHM 44nm respectively.
In R2 of the keratinocyte trials the NFK cells were thawed out of cryopreservation state and
cultured in T75 flasks. Three days later the cells were passed into 6 four-well slides. As a
consequence of not having the same four-well slides available that were used in the first round of
keratinocyte trials, the keratinocytes were passed into the alternate four-well slides with the thick
specimen slide base. As a result of low observed confluency, additional cells, from the initial T75
flasks, were added to the 6 four-well flasks on 3 days after the first passage into the 6 four-well
slides. Three feedings of keratinocyte media were administered in the interim between the initial
thawing and the addition of cells. The 6 four-well slides were divided into 3 sets: a, b, and c. Each
well-set was examined with the optical microscope before the introduction of the test solutions and
at their individual time points post-introduction. Conditions in well-set a were scheduled to be
investigated one hour after the introduction of the test solutions, conditions in well-set b at 12 hour
post-introduction, and well-set c 24 hours post introduction of the test solutions. Although the time
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points for investigating the conditions in well-sets b and c did follow the initial schedule, the initial
schedule for well-set a was altered to accommodate the hurdles of using the four-well slides
mounted on the thick specimen slides bases, the missing Hoechst stain, and the lights in the
engineering building that housed the confocal microscope being shut off previous to imaging well
sub-set a2.5-8.
4.2.1.3 Duration of Keratinocyte Trial – R1
The first round of keratinocyte trials explored two different time-frames. Well-set a
examined the cell-QD construct interaction and effect of the test solutions on cell viability and
proliferation for a 24 hour exposure time and well-set b explored the cell-QD construct interaction
and effect of the test solutions on cell viability and proliferation for a 24 hour exposure time with
an additional latent period of 24 hours in fresh media. In other words, well-set b underwent the
same initial conditions as well-set a, but after the initial 24 hours of exposure, the test solutions
were aspirated off, fresh media was added, and another 24 hours of incubation time was initiated.
The purpose of this tactic was to assess the longer term consequences of the cells to a discrete
exposure of the test solutions.
The cells were removed from the primary aseptically maintained incubator and examined
under a white light microscope. Observations of cell confluency and morphology, and the presence
of any contaminants, were recorded and representative images of each well-chamber were taken
using a Sony Cyber-Shot digital camera on low light high sensitivity setting at maximum zoom
without a flash. After imaging the cells pre-introduction of the test solutions was completed, the
choice to aspirate or not to aspirate was made. The decision to aspirate off the initial media present
in the cultures before introduction of the test solutions was dependent upon three factors: the time
relative to the most recent feeding, the amount of media residing in each of the culture wells, and
the desired dilution of the test solutions. If the last feeding was more than 24 hours prior to
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introduction of the test solutions, the initial media was aspirated out of the wells and the
appropriate amount of media, relative to the desired dilution of the test solutions, was added. If the
time between the introduction of the test solutions and the most recent feeding did not necessitate
new media but the wells were full, and therefore did not have room to add the test solutions, the
media was aspirated off. Ideally, enough media would be available to support the decision to
aspirate off the initial media, add fresh media to the test solutions achieving the desired dilution,
and then add the test solutions to the cell cultures. After the media was aspirated off, using a motor
powered aspiration system, the test solutions were added to each well, and the cultures were then
placed in the secondary incubator and maintained at a temperature of 37°C.
Twenty four hours after the introduction of the test solutions both well-set a and well-set b
were removed from the secondary incubator and all wells were aspirated, removing the test
solutions. Each well of well-set b was then rinsed with 0.5ml of keratinocyte media, aspirated,
filled with 3 mL of keratinocyte media, re-imaged, and placed back into the secondary incubator.
Observations of cell confluency and morphology, and the presence of any contaminants were
recorded with corresponding representative images for each well-chamber. These images were later
compared with the corresponding confocal images. 1.5mL of keratinocyte culture media was added
to each well of well-set a and the cultures were again examined under the microscope; no images
of well-set a were taken at this time.
4.2.1.4 Duration of Keratinocyte Trial – R2
Three different time points were investigated in the second round of trials: one hour, 12
hours, and 24 hours post-introduction of test solutions. The purpose of these time points was twofold: to determine the proportion of cell damage relative to time of exposure and to determine the
rate of attachment and of QD constructs to cell membranes. Each four-well slide was removed
from the primary incubator and examined using the optical white light microscope. As a result of
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diminished stores of fresh keratinocyte media on hand, the existing media in each of the wells,
approximately 1mL, was not removed. All test solutions were introduced to the cultures, 1.5mL per
well, and the slides were placed in the secondary incubator at 37°C. The L/D stain solution was
made during the one hour waiting period for the first set of slides to incubate. The Hoechst dye
material was unavailable for use in well-set a and was therefore not implemented until testing of
well-set b. At one hour from introduction of the test solutions well-set a was removed from the
secondary incubator.
Table 4.3 Keratinocyte Trial Time Points in Round Two

4.2.2 Implementation of White Light Optical Imaging
At the onset of each trial, the previously prepared four-well flasks were removed from the
primary incubator and viewed before adding the test solutions. Each well of keratinocyte cell
cultures was examined using an Olympus CKX41 optical white light microscope at magnifications
of both 10X and 20X with the intermediate light aperture. Examination of the cells was performed
to qualitatively classify the general appearance and morphology of the cells within the culture, both
as individual cells and as a culture population. Individual cell morphologies were examined by
assessing cell shape, size, and adhesion according to the characteristics as described by the
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distributor of the keratinocyte cells, ATCC Primary Cell Solutions. The expected morphology,
developmental phase, and distribution, indicative of healthy cells, are a cobblestone appearance,
high mitotic index, colony formation of cells when at near 80% confluency, and cell adherence to
the well-plate surface (81). A cobblestone appearance is characterized by individual cells that are
rounded not flat. Mitotic Index refers to the ratio of cells within the culture population that are
actively undergoing mitosis relative to cells not undergoing mitosis (82). The keratinocyte cell
culture images in Figure 4.4 show these representation fundamental keratinocyte culture
characteristics at four different percentages of confluency. In addition to these fundamental cell
traits, any anomalies found within each well were also assessed and recorded to be later referenced
in the case of unexpected developments within the cultures at a later time point.

Figure 4.4 Microscopic view of neonatal foreskin keratinocytes (NFK) at different stages of
proliferation and colonization: a. initiation of NFK cells, day 8 after seeding; b. growing colonies
at day 11; c day 15; d. confluent area at day 20 (83).

89

4.2.2.1 Optical Imaging – R1
A minimum of three initial images were taken for each well in both well-set a and well-set
b. Multiple images of each well were taken to ensure that an accurate representation of the state of
the whole culture was recorded pre-introduction of the test solutions. These first images were taken
with the initial media still present in each well. The purpose of imaging before removing the initial
media was to ensure that any dead cells or contaminants contained within the media would be
included in the initial observations. Had the initial media been aspirated off before imaging, these
abnormalities would have gone unidentified. The wells were then aspirated and the test solutions
were then added to both well-sets, 1.5mL per well without additional fresh media, and both wellsets were placed back into the secondary incubator. At the 24 hour mark well-set b was removed
from the secondary incubator, the test solution in each well was aspirated off, 1.5mL of fresh media
was added, and another set of images were taken using the white light optical microscope. After the
representative images were taken, well-set b was placed back into the incubator for a final period
of 24 hours. At this time, after well-set b was returned to the incubator, the test solutions were
aspirated off of well-set a. After aspiration of the test solutions 0.5mL of keratinocyte was added to
each well and used to rinse off any remaining test solution. The rinse was then aspirated off and a
second volume of 0.5mL of keratinocyte media was added. This additional 0.5mL of media was
added as part of the preparation for staining the cells with the Calcein/EthD-1 Live/Dead (L/D)
stain. No images of well-set a were taken after aspiration of the test solutions. Forty eight hours
after the initial, 24 hours after well-set b had been returned to the secondary incubator with fresh
media, the optical microscope was once again used to image each well in well-set b. Through
visual observation it was determined that little to no change had occurred in the cells during the 24
hours since the last viewing and therefore no additional white light images of well-set b were
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taken. To more clearly illustrate the time line of test solution introduction and imaging, Figure 4.5
gives the sequence of events in detail.

Figure 4.5 Sequence of Cell Culture – Test Solution Interaction and Imaging

4.2.2.2 Optical Imaging – R2
The pattern of imaging each well-set in the second round of trials was similar to that of the
pattern of imaging for the first round of trials, but in this case all well-sets were imaged both before
and after the introduction of the test solutions. All three well-sets, a, b, and c, were removed from
the primary incubator and imaged, before introduction of the test solutions, with the initial media
still in each well. After imaging each well, and recording all pertinent observations, 1.5mL of the
test solution corresponding to each well was added. Unlike the first round of trials the initial media
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was not aspirated off before the introduction of the test solutions. Not aspirating off the initial
media before introduction of the test solutions was the result of having only a limited supply of
keratinocyte available. All of the well-sets were then placed back into the secondary incubator. At
one hour after the introduction of the test solutions well-set a was aspirated, rinsed with 0.5mL of
keratinocyte media, aspirated, rinsed with 0.5mL of keratinocyte media, and then re-imaged with
the optical microscope before introducing any fluorescence staining. This same series of rinsing
with the stain-associated media, aspirating, and imaging was applied to well-sets b and c at 12 and
24 hours respectively.
4.2.3 Fluorescence Staining
Two varieties of fluorescent staining methods were employed for determining the cell
viability of the keratinocyte cultures post-introduction of test solutions and the degree of cell-QD
construct interaction: Calcein/Ethidium homodimer-1 (EthD-1) Live/Dead cell viability stain (L/D)
and Histochoice/Hoechst (H/H) nuclei stain. The application of the L/D stain was used to
simultaneously test two separate parameters of cell viability: intracellular esterase activity and
plasma membrane integrity (84). It is the esterase activity inherent in all live cells that acts as a
catalyst causing a conversion of the non-fluorescing calcein AM in the L/D stain solution to the
green fluorescing species calcein (84). As the period of time that a cell has been dead increases,
less and less calcien AM is available to be converted into calcein, resulting in a corresponding
decrease of fluorescence. Although the presence of the calcein associated green fluorescence isn’t a
negative for dead cells, it does indicate that at the time of the introduction of the L/D stain there
was still intracellular esterase activity in the cell; an indication that the cell was most likely alive at
the time of the introduction (85). EthD-1 is used to determine the presence of dead cells in the
culture. EthD-1 can only enter cells with damaged membranes. Previous to entering the cells the
level of EthD-1 is low enough to be hidden in the background noise. It is only upon invasion in to
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the cell through the permeable membrane, and binding to the nucleic acids within the cell, that the
EthD-1’s red fluorescence signature is observed (84). Any amount of red fluorescence in a cell is
an indication that the cell’s membrane has become permeable as a result of cell death. A cell that
fluoresces almost entirely green but that does exhibit some red fluorescence is an indication of
recent cell death; possibly as a direct result contact with the L/D stain. A cell that fluoresces
almost entirely red is an indication that cell death was not recent; most probably a result of
environmental factors unrelated to the L/D stain. The excitation wavelength for both calcein and
EthD-1 is 495 nm, with calcein having and emission wavelength of 515nm and EthD-1 having an
emission wavelength of 635nm. The L/D stain solution applied to both R1 and R2 trials was made
using Invitrogen’s Live/Dead Viability/Cytotoxicity Kit.

Figure 4.6 On the left is the excitation and emission fluorescence spectra of Calcein (495/515), on
the right is the excitation and emission spectra of EthD-1 (495/635) (86, 87).
The Hoechst stain used in the R2 trials was Invitrogen’s Hoechst 34580. This particular
variety of Hoechst has can be excited using a 405nm wavelength laser and is therefore appropriate
for use when imaging with a confocal microscope. Hoechst stains are cell permeable nucleic acid
stains (83). Hoechst 34580 was used in this thesis to positively confirm the presence of
93

keratinocyte cell nucleuses from other biologic entities that may have been present in the cultures
and which may have reacted with the L/D stain and QD constructs in R1, but were not in fact
keratinocyte cells.

Figure 4.7 The excitation (solid line) and emission (dotted line) fluorescence spectra of
Invitrogen’s Hoechst 34580 stain (88).
4.2.3.1 Calcein/EthD-1 Live/Dead Cell Viability Stain – R1and R2
In R1, as well as R2, the L/D stain was made by mixing 20µL of 2mM EthD-1, 10mL of
keratinocyte media, and 5µL of 4mM Calcein in a 20mL glass vial. The solution was vortexed and
the glass vial was wrapped in aluminum foil to prevent a reduction in the stains efficacy resulting
from over exposure to light. For both rounds of keratinocyte trials the L/D stain was prepared and
applied to the cultures in the same manner and in the same time frame. The well sub-set to be
imaged was aspirated to remove the test solutions, rinsed with 1.5mL of keratinocyte media,
aspirated again, and another 1.5mL of keratinocyte media was added. The entire protocol for the
preparation and use of the L/D stain is given in Appendix B.9. The L/D stain was not added to the
cell cultures until 10 minutes before imaging with the confocal microscope. This delay in
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administering the L/D stain was used as a measure for decreasing the influence that the stain had on
the health of the cells.
4.2.3.2 Histochoice/Hoechst Nucleus Stain – R2
The Hoechst stain was applied in the R2 trials only. The protocol used for the preparation
of the Hoechst stain was originally created for staining coverslips coated with NIH 3T3 fibroblast
cells. This original protocol of the Hoechst stain called for preparation of a 2µg/mL concentration
solution of Hoechst dye using a 5mg/mL stock solution and applying 200µL of the solution to each
coverslip. This concentration could be achieved by mixing 2µL of the stock solution with 5mL of
PBS. For the preparation of the Hoechst stain for use in the four-well slides of keratinocyte
cultures, alterations were made to the original protocol. The Hoechst starting material on hand was
in powder form, not liquid, and therefore was not measured out by mixing 2µL of Hoechst with
5mL of PBS. Instead, Hoechst stain was prepared by adding 2 – 4 particles of the Hoechst powder
with 5mL of PBS in a glass vial and vortexing the solution. The glass vial was then wrapped in
aluminum foil to prevent a decrease in the effectiveness of the solution as a result of exposure to
light.
Each well-set in R2 had been divided into two subsets: a, b, c1.1-4 and a, b, c2.5-8. In the
casee of well-set a, well-subset a1.1-4 was to receive the Histochoice fixative and Hoechst stain
(H/H), well-subset a2.5-8 was to receive the L/D stain. Each stain was to be prepared in a different
aqueous medium, PBS for the H/H and keratinocyte media for the L/D; therefore, each well-subset
was to be rinsed with 0.5mL of the media corresponding to the stain that would be administered to
that particular subset. The same pattern of aspiration, imaging, and rinsing was to be applied to
well-sets b and c at 12 and 24 hours respectively from the initial introduction of the test solutions
into the well-sets. The proposed schedule of staining was administered as intended for well-sets b
and c, however, well-set a did not receive the H/H staining as a result of the Hoechst stain base
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material being unavailable; instead both sub-sets received L/D stain. Additionally, as a
consequence of using the alternate four-well slides with the thick specimen slide base, sub-set a1.14 was exposed to the L/D for an extended period of time before imaging with the confocal
microscope; sub-set a2.5-8 was imaged 24 hours after sub-set a1.1-4 as a consequence of the lights
in the building being turned off just before the L/D stain was to be introduced.
4.2.4 Confocal and DIC Imaging
An Olympus Fluoview confocal microscope was used to acquire confocal and differential
interference contrast (DIC) images. Confocal images of the cell cultures exposed to the L/D and
H/H stains were acquired by applying the Alexafluor 488 filter to detect the Calcein emission, the
PI filter to detect the EthD-1 emission, the Qdot565 filter to detect the QD construct emission, and
the DAPI filter to detect the Hoechst stain emission. In the cases of imaging cell viability in wells
that contained QD constructs, it was not possible to employ both the L/D and QD filters
simultaneously owing to the overlap between the excitation and emission wavelength ranges
associated with each filter. In this circumstance separate images were taken of the same field of
view and then compared side by side. DIC images provided topological information about the
structure of the cell cultures in each well. Using DIC imaging in concert with confocal imaging
offered an additional method for determining the relative position of the QD constructs with
respect to the cells. DIC images were obtained by applying the TIC filter.
4.2.4.1 Keratinocyte Cell Viability – R1
The first round of keratinocyte trials investigated cell viability and cell-QD construct
interaction using only L/D staining and confocal imaging of the wells. The L/D stain was applied to
each well sub-set, placed in a closed container out of the light, and allowed to incubate for 10
minutes before imaging. Each four-well slide was placed securely above the 20X objective lens.
Before attempting to acquire an image, the wide-field fluorescence laser was engaged and the
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sample viewed through the eyepiece while adjusting the vertical position of the four-well slide
relative to the objective lens until a clear image was achieved. After achieving a clear image in this
manner, scanning of the image using the confocal laser and appropriate filters was initiated. A
strategy of acquiring multiple images, at different focal depths, taken of a single area while
adjusting the intensity of the laser was applied. The amount of the excitation laser source incident
on the sample was adjusted by increasing or decreasing the “laser %” on the control panel. An
additional adjustment made in an effort to achieve maximum clarity of the cells and minimum
interference of background fluorescence was manipulation of the high voltage (HV) setting
associated with each filter. Each well within both well-sets a and b were imaged with this strategy.
As a result of the distinct emission wavelength of the QD constructs, CMW of 539 nm with
a FWHM of 44nm, it was possible to distinguish the QD constructs from the cells when viewing
the wells with the L/D stain associated filters alone. For clarification that the particles presumed to
be QD constructs were in fact QD constructs, images of the same field of view within the wells
containing the QD construct test solutions were taken using the L/D filters and then again using
only the Qdot565 filter. These images were then assessed in a side by side comparison.
4.2.4.2 Keratinocyte Cell Viability – R2
The second round of keratinocyte trials investigated cell viability and cell-QD construct
interaction using L/D staining, H/H staining, and confocal and DIC imaging of the wells. As stated
in Section 4.2.4.2, a consequence of using the alternate four-well slides with the thick specimen
slide base, was that sub-set a1.1-4 was exposed to the L/D for an extended period of time before
imaging with the confocal microscope. The particular difficulty associated with using the alternate
four-well slides stemmed from the thickness of the specimen slide base. The added thickness,
relative to the four-well slides used in R1, prevented clear and accurate imaging with the confocal
microscope. To combat this, directly before imaging, the solution within each well was aspirated
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off and the four-well chamber frame was removed. Removal of the four-well chamber frame left
behind the rubber seal that had attached the frame to the slide. The formation and height of the
rubber seal was such that when a cover slip was placed over the area previously occupied by the
frame, there was still a significant gap between the coverslip and the cells. This gap precluded
acquiring clear images. This was remedied by removing the rubber seal. In the case of well sub-set
a1.1-4, the seal was removed using a metal spatula and tweezers. Removal of the rubber seal for
well sub-set a2.5-8 and well-sets b and c employed the use of a razor blade and tweezers. The
progression of slide alterations is given in Figure 4.8.

Figure 4.8 Adaptation of four-well with thick specimen slide base for use in confocal imaging of
R2 keratinocyte trials. A. Four-well slide with well chambers. B. Four-well slide with rubber seal.
C. Four-well slide ready for imaging.

As a result of the incompatibility of the Alexa Fluor 488 and PI filters with the DAPI and
Qdot565 filters, multiple images of the same field of view within each well were taken. All of the
wells were imaged with the Alexa Fluor 488, PI, DAPI, Qdot565 and TIC filters to assess cell
viability, location, and structure. Well sub-sets a, b, c3.5-8, which contained the QD construct test
solutions, were imaged with the application of the Qdot565 filter as a method for accurately
distinguishing the QD constructs form the cells. Wells not containing QD constructs were imaged
with the Qdot565 filter to assess how non-QD construct entities would appear when the filter was
applied. The excitation/emission wavelength ranges associated with the Hoechst stain and the QD
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constructs were very similar. This similarity introduced wavelength of the laser used for the
excitation of the Hoechst and QD-constructs

4.3 Results
4.3.1 QD Construct Introduction into Keratinocyte Cell Cultures
4.3.1.1 QD Construct Control and Test Solutions – R1
Each of the steps in creating the final QD construct solution resulted in alterations of the
samples CMW, intensity, FWHM, and scattering of the excitation source. The progression of these
changes is documented in Table 4.4 and Figures 4.9, 4.10, and 4.11. Two different graphs were
created to illustrate the different CMW and intensities related to each stage in the QD construct
progression. The graph in Figure 4.9 gives the fluorescence spectrums of the CdSe core sample
42612wCMBO.2 as well as each of the CdSe core samples from which it was comprised. The
general shapes of all of the samples are indicative of the typical spectrum for a white core sample;
one primary peak at 490 ± 10nm and a broad rolling peak between 550 and 650 nm. Filtering of the
initial R1 QD construct solution with a 0.45 micron filter resulted in a noticeable difference in the
CMW, from 552nm to 539nm, of the QD construct solution. Changes in intensity were minimal,
and changes in FWHM were non-existent.
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Table 4.4 Progression of Changes in Fluorescence Spectrum During Synthesis of QD Construct
Solution 42612wEN.2a
Sample

11211AR1.5
2912AC1.0
21412AC1.0
21712AC1.0
22912AC1.0
42612wCMBO.2
42612wQD.2a
42612wEN.2a - NF
42612wEN.2a - 0.45µm filter
PL/krt [10mg/mL] - 0.2 µm filter
PL/krt [10mg/mL] - 0.45 µm filter

Primary
Peak CMW
(nm)
486
490
486
473
485
487
550
552
539
524
524

Intensity
(counts)

FWHM (nm)

4200
7700
6000
5500
6400
6600
3000
16500
14600
2400
2400

50
44
44
-

Source
Scattering
(counts)
1300
500
1300
> 70000
> 70000
> 70000

CdSe Core Sample Composition of 42612wCMBO.2

Intensity (counts)

10000
8000

11211AR1.5
2912AC1.0

6000

21412AC.0
4000

21712AC1.0
22912AC1.0

2000

42612wCMBO.2
0
250

350

450

550

650

750

850

Wavelength (nm)

Figure 4.9 CdSe combination core sample (42612wCMBO.2 – orange) and the five CdSe core
samples from which it was composed.
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Intensity (counts)

Synthesis Progression of 42612wEN.2a QD Construct
20000
18000
16000
14000
12000
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6000
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2000
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42612wCMBO.2
42612wQD.2a
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42612wEN.2a - not filtered
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Figure 4.10 Changes in CMW, intensity, FWHM, and source scattering corresponding to solutions
at each step in the QD construct synthesis process.

Phospholipid Encapsulation Progression of 42612wEN.2a
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Figure 4.11Changes in CMW, intensity, FWHM, and source scattering corresponding to the
influence of phospholipid concentration.
A useful option for qualitative assessment of the changes in CMW and intensity of each solution in
the progression of QD construct development was found to be visual assessment of the samples
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during exposure to a UV source. Figure 4.12 provides a visual representation of each of the
samples fluorescing.

Figure 4.12 Progression of QD construct samples during exposure to a 400nm emitting black light.
From left to right: Original CdSe core combination sample; CdSe/ZnS QD sample shelled at
160°C; Phospholipid encapsulated QD construct solution after application of 0.45µm filter;
Phospholipid encapsulated QD construct solution NOT filtered; PL/krt [10mg/mL] NOT filtered;
PL/krt [10mg/mL] with application of 0.45µm filter.
4.3.1.2 QD Construct Control and Test Solutions – R2
Although more data samples would be needed to definitively determine the effects of
increased filtering on CMW, intensity, and FWHM of the QD constructs, quantitatively the effects
appeared to be insignificant. Qualitatively, however, a visual comparison of the filtered samples
showed a slight difference in the intensities of the two samples, as well as a noticeable shift in
wavelength. It appeared as though the sample filtered through the 0.2 micron filter had a decreased
wavelength relative to the sample filtered through a 0.45 micron filter.
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Effects of 0.2 micron Filtering on QD Construct CMW, Intensity, and FWHM
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Figure 4.13 Fluorescence spectra of QD construct test solutions 42612oEN.1a and
52312EN45.60b filtered with 0.45 and 0.2 micron filters.
4.3.1.3 Optical Imaging – R1
The initial images of both well-sets of cell cultures, pre-introduction of the test solutions,
showed a noticeable degree of contamination in each culture. Additionally, a noticeable amount of
cell-like structures appeared at a higher focal plane and with a different morphology than the cells
adhered to the surface of the well. Upon shaking of the four-well slide the cell-like structures
jiggled but maintained their general position in the well. Had the cell-like structures fully detached
from the surface of the well and freely moved in the upper portion of the media during agitation,
the condition would have typically indicated that the cells were dead (89). The series of images in
Figure 4.14 a representative example of the keratinocyte cell cultures as they appeared after being
removed from the primary incubator before the aspiration of their initial media and introduction of
the test solutions. In both sets of images contamination already appears to be present.
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Figure 4.14 Digital white light optical images of R1a1.1, fresh media control, taken at different
light intensities of the well pre-introduction of test solutions while the initial media was still
present.

At the 24 hour time point post-introduction of the test solutions, the test solutions in the
wells of well-set b were aspirated, rinsed with keratinocyte media, and imaged. All of the images
show unidentified black orbs of unknown origin. A comparison of well b1.3 before and after the
introduction of the test solutions is given in Figure 4.15. Images A1-3 are of the well b1.3, into
which the test solution of keratinocyte media that had undergone the process involving exposure to
both CHCl3, heating to 55°C, and evaporation, would later be introduced. Images B1-3 are of this
same well, b1.3, after a 24 hour exposure to the test solution, aspiration of the test solution and
addition of fresh media.
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Figure 4.15 Digital white light optical images of R1b1.3 (keratinocyte media post CHCl3
evaporation control) taken at different light intensities. A1-3. Pre-introduction of test solutions
while the initial media was still present. B1-3 Post-introduction of test solutions after aspiration and
rinsing with fresh media
4.3.1.4 Keratinocyte Cell Viability and Cell-QD Construct Interaction – R1
The confocal equivalents of the white light optical images of well b1.3 are given in figure
4.16. Images A1, 2 and images B1, 2 each show two focal depths of a single field of view. In an
attempt to discern the effect of the extended exposure of the cells to the L/D stain, a result of the
time inherent to the process of imaging each well, a series of confocal images of well b1.1 is given
in figure 4.17. These images taken are of cells that had only been exposed to the L/D stain for
approximately 10 minutes. Each image is of the same well but at different fields of view and at
sequentially lower focal planes. The order of the images is the order in which they were taken;
approximately one minute passed in between capturing each image. As the images progress toward
the right an increase in the number of cells fluorescing red, and therefore dead, can be detected.
This increase in the appearance of dead cells is more influence by the change in focal plane than by
the minute passage of time. The left most image is of the highest focal plane, the image farthest
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right is of the lowest focal plane; cells at the top of the culture versus cells closest to the surface of
the slide, respectively.

Figure 4.16 Confocal images acquired of well b1.3 (processed krt media control). A1. Two focal
planes of one field of view. B1. Two focal planes of one field of view. Filters: Alexa Fluor 488
and PI

Figure 4.17 Series of confocal images of well b1.1 (fresh krt media control) at different fields of
view and different focal planes. Filter: Alexa Fluor 488 and PI

Aside from the addition of the black orbs (bos), the average morphology and distribution of the
cells in well b1.3 did not appear to be noticeably different from their appearance before the
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addition of the test solutions. The appearance of the orbs was consistent throughout all of well-set
b. The orbs appeared at greatest visual clarity at the same focal plane in which the cells appeared
to be at the greatest visual clarity. The orbs were not distinguishable in the corresponding confocal
images using the Alexa Fluor 488 and Pi filters shown in Figures
4.18 C1 -3.

Figure 4.18 A1-3: Series of white light images of well b2.6 (PL krt filtered) pre-introduction of
test solutions at different fields of view. B1-3 Series of white light images of well b2.6 postintroduction of test solutions at different fields of view. C1-3 Series of confocal images of well
b2.6 in the same field of view at different focal planes. Filter: Alexa Fluor 488 and PI
In both the white light optical images and confocal images of well b2.7 the presence of the
phospholipids, filtered using a 0.45 micron filter, are clearly distinguishable. A span of images at
three focal lengths was employed for the detection of dead cells fluorescing red. In the upper left
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corner of the confocal images in row C, a structure unlike the cells is apparent. This structure could
be representative of a black orb, made visible by the dense cell coverage.

Figure 4.19 A1-3: Series of white light images of well b2.7 (PL krt NF) pre-introduction of test
solutions at different fields of view. B1-3 Series of white light images of well b2.7 postintroduction of test solutions at different fields of view. C1-3 Series of confocal images of well
b2.7 in the same field of view at different focal planes. Filter: Alexa Fluor 488 and PI.

Figure 4.20 gives a progression of images from the cultures exposed to the 0.45 micron filtered QD
construct solution. Multiple black orbs were detected 24 hours after the introduction of the test
solution. The structures identified as cells, those fluorescing both red and green with an obvious
nucleus, show some evidence of interaction with the QD constructs. The wholly green spheres are
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may be the orbs and also show interaction with the QD constructs. The upper left sphere in C2 and
the sphere in figure 4.20 each show a distinct QD halo indicating active interaction with the QDs.

Figure 4.20 A1-3: Series of white light images of well b3.10 (QD PL krt filtered) pre-introduction
of test solutions at different fields of view. B1-3 Series of white light images of well b3.10 postintroduction of test solutions at different fields of view. C1-3 Series of confocal images of well
b3.10 in the same field of view at different focal planes. Filter: Alexa Fluor 488 and PI.
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Figure 4.21 Digital image of well b3.10 as seen through the objective lens of the confocal
microscope viewed with illumination from the wide-field fluorescence laser

Figure 4.22 A1. Confocal image of a seemingly burst cell in well b3.10 (QD PL krt filtered) A2.
Digital image of burst cell in b3.10 as seen through the objective lens of the confocal microscope
viewed with illumination from the wide-field fluorescence laser.
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Figure 4.23 A1-3. Series of L/D filter confocal images of well a3.9 (QD PL krt filtered) A4
Qdot565 filter. B1-3. Series of L/D filter confocal images of well a3.9 (QD PL krt filtered) B4
Qdot565 filter.

Figure 4.24 Digital image of well a3.9, representative of the series A1-4 in figure 4.23 as seen
through the objective lens of the confocal microscope viewed with illumination from the wide-field
fluorescence laser.
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Figure 4.25 A1-3: Series of white light images of well b3.12 (QD PL krt NF) pre-introduction of
test solutions at different fields of view. B1-3 Series of white light images of well b3.12 postintroduction of test solutions at different fields of view. C1-3 Series of confocal images of well
b3.12 in the same field of view at different focal planes. Filter: Alexa Fluor 488 and PI
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Figure 4.26 Series of confocal images of well a3.11 (QD PL krt NF) at the same field over a series
of focal planes. Filters: A1-4 Qdot565, B1-4 Alexa Fluor 488 and PI

Figure 4.27 Digital image of a3.12 (QD PL krt NF) as seen through the objective lens of the
confocal microscope viewed with illumination from the wide-field fluorescence laser.
4.3.1.5 Imaging – R2
All of the initial cell cultures showed similar levels of minimal contamination and cell
confluency, approximately 60%, at the time of extraction form the primary incubator and before
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the introduction of the test solutions. Figure 4.26 gives a sampling of the culture appearance from
each well-set pre-introduction of the test solutions. At one hour post- introduction of the test
solutions well-set a showed, on average, two of the spherical unknowns for every three wells.
There was no apparent correlation between the test solution administered to the well and the
appearance of the bos. Wells that had contained controls of fresh keratinocyte media, phospholipids
in keratinocyte media, QD constructs, and both levels of filtration all contained at least one black
orb when all of the related wells were considered as a group. Figure 4.27 gives a sampling of the
culture appearance from each well-set post-introduction of the test solutions. The sample includes
images representing each of the three time points along with each of the test solutions.
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Figure 4.28 Representative images taken with a white light optical microscope pre-introduction of
the test solutions. A. well-set a. B. well-set b. C. well-set c, a single field of view at three different
focal planes to better illustrate the culture composition.
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Figure 4.29 Representative images taken with a white light optical microscope post-introduction of
the test solutions. A1,2. a1.4 QD PL B 0.2 micron filter. A3. a1.2 QD construct A 0.2 micron filter.
A4. a2.8 PL 0.45 micron filter. A5. c1.3 PL 0.2 micron filter. A6. c1.4 QD construct B 0.2 micron
filter.
4.3.1.6 Keratinocyte Cell Viability and Cell-QD Construct Interaction – R2
Confocal images of well sub-set a1.1-4 lacked clarity as a result of the first method applied
in the arrangement of the cover-slip and specimen slide. The two images acquired at one hour post
introduction of the test solutions are given in Figure 4.28. The images are of well a1.1, which
contained the keratinocyte media control solution and was prepared with the L/D stain. An
additional effect of the slide preparation issue was the delayed imaging of well sub-set a2.5-8. All
images of well sub-set a2.5-8 were taken 24 hours after the test solutions had been removed; the
wells were rinsed and subsequently left covered but un-incubated for 24 hours. As a result of the
Hoechst stain being unavailable for use in well-set a, there are no confocal images of well-set a
with the DAPI filter applied; all images are of cultures exposed to the L/D stain and the imaged
using the Alexa Fluor 488, PI, Qdot565, and TDI filters.
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Figure 4.30 Well a1.1 (keratinocyte media control). A1. Alexa Fluor 488 and PI filter. A2. Alexa
Fluor 488, PI, and TDI filter overlay.

The confocal images taken of the wells exposed to the QD construct test solutions showed a
minimal presence of QD constructs in the culture. The yellow arrow in Figure 4.29 indicates the
single QD construct that was visible in that field of view of well a2.5. An additional series of
images using each filter was applied to well b1.4, also exposed to a QD construct test solution.
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Figure 4.31 Comparison of well a2.5 (QD construct A 0.45 micron filter) in row A with well a2.6
(keratinocyte media control) in row B. Column 1 - Alexa Fluor 488 and PI filter. Column 2 –
Qdot565 filter. Column 3 – Qdot565 overlaid with TDI. Column 4 - Alexa Fluor 488 and PI with
TDI filter overlay. The yellow arrow points to a QD construct.

Figure 4.32 Series of confocal images taken of b1.4 (QD construct B 0.2 micron filter). Filters
applied: A1- Alexa Fluor 488; A2 – PI; A3 – TDI; A4 – Qdot565; A5 - Alexa Fluor 488 and PI;
A6 - Alexa Fluor 488, PI, and TDI; A7 - Qdot565 and TDI.
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The series of images in Figures 4.33 and 4.34 both indicate the identification of QD
constructs. Well b2.5 of figure 4.33 did contain cells exposed to QD constructs. Well b2.6 in Figure
4.34 did not contain QD constructs. Well b2.6 contained only keratinocyte media. The
identification of QD contructs in this well is a false identification the result of the Hoechst stain
being excited by the 405 excitation wavelength and the subsequent emission form the Hoechst stain
being detected by the Qdot565 filter. Figures 4.35 and 4.36 give a side by side comparison, of the
same field of view, for images resulting from use of the 405nm excitation source versus that of the
488nm excitation source. These images illustrate the false identification of QD constructs when
the 405nm laser is applied to wells with the Hoechst stain and detected with the Qdot565 filter.
Additionally these images show that an excitation wavelength of 488nm does not produce a false
positive for the presence of QC constructs.

Figure 4.33 Series of confocal images taken of b2.5 (QD construct A 0.45 micron filter). Filters
applied: A1- DAPI; A2 – Qdot565; A3 – TDI; A4 – DAPI and Qdot565; A5 - DAPI, Qdot565, and
TDI; A6 - Qdot565 and TDI.
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Figure 4.34 Series of confocal images taken of b2.6 (keratinocyte media control) comparing
excitation wavelengths of 405 and 488nm. Row A utilizing 405nm and row B utilizing 488nm.
Filters applied: A1- DAPI; A2 – Qdot565; A3 – DAPI and Qdot565; A4 - DAPI, Qdot565, and
TDI; B1 – DAPI; B2 – Qdot565; B3 – Qdot565 and TDI.

Figure 4.35 Series of confocal images taken of b2.7 (QD construct B 0.45 micron filter) comparing
excitation wavelengths of 405 and 488nm. Row A utilizing 405nm and row B utilizing 488nm.
Filters applied to each column: 1- DAPI; 2 – Qdot565; 3 – DAPI and Qdot565; 4 – Qdot565 and
TDI; 5 – DAPI, Qdot565, and TDI.
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When comparison of the number of live to dead cells was made, comparing the effect of
each test solution on cell viability, no significant difference was determined to be present. All
wells, on average, had the same ratio of live to dead cells. Figures 4.36 and 4.37 give a set of
images representative of the entire culture surface of each analyzed well. Figure 4.37 compares a
series of images of wells, using the same application of filters, to determine the relative signatures
of cells, QD constructs, and phospholipids specific to each filter: Alexa Fluor 488, PI, Qdot565,
and TDI. Each image contains structures that fluoresced red. Only row B, wells exposed to QD
constructs, contains a bright yellow structure in images B1 and B3, corresponding to the same
position of the structure identified in B2 as being a QD.

Figure 4.36 Series of confocal images taken of c2.5 (QD construct A 0.45 micron filter) Filters: A1
- Alexa Fluor 488 and PI; A2 – Qdot565; A3 – Qdot565 and TDI; A4 – Alexa Fluor 488, PI, and
TDI
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Figure 4.37 Comparison of confocal images: of c2.6, row A (keratinocyte media control); c2.7.
row B (QD construct B 0.45 micron filter); c2.8, row C (phospholipid keratinocyte media 0.45
micron filter). Filters applied to each column: A1 - Alexa Fluor 488 and PI; A2 – Qdot565 and
TDI; A3 – Alexa Fluor 488, PI, and TDI. The yellow arrow indicates a QD construct.

An additional series of 405nm versus 488nm images were conducted on the Hoechst stained
cultures of well-set c. The subsequent images, given in figure 4.38, return the same results as seen
previously in the images taken for the Hoechst stained cultures of well-set b.
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Figure 4.38 Series of confocal images taken of c1.1 (keratinocyte media control) comparing
excitation wavelengths of 405 and 488nm; images A1-5 utilizing 488nm and image A5 utilizing
405nm. Filters applied to each column: 1- DAPI; 2 – Qdot565; 3 – TDI; 4 - DAPI and Qdot565; 5
– DAPI, Qdot565, and TDI; 6 - DAPI, Qdot565, and TDI.

4.4 Discussion
4.4.1 QD Construct Introduction into Keratinocyte Cell Cultures
4.4.1.1 QD Construct Control and Test Solutions – R1
Each step in the process for creating the QD constructs had an effect on the CMW of the
solution. The encapsulation of the QDs in the phospholipid micelles and the filtering of the
subsequent solution both resulted in a decrease CMW. There are two possible explanations for this
effect: the QDs inside the micelles have a decreased diameter and/or the phospholipids absorb a
portion of the energy from the excited electron in the form of phonons, thus reducing the energy of
the emitted photon. As described in chapter one, a decrease in the size of QDs will result in a
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decrease in the emission wavelength. It could be possible that during the encapsulation process the
QDs de-aggregate into smaller particles. However, knowing that exposure to heat, which the
encapsulation process includes, typically promotes aggregation of QDs and thereby increases
emission wavelengths; it seems unlikely that the decreased emission wavelength is the result of the
size of the QD being diminished. The more likely reason is that the presence of the phospholipids
surrounding the QDs removes energy. Filtering of the test solutions also resulted in a shift of
noticeable shift in wavelength and intensity; again the result being a decrease. Filtering inevitably
removes a significant proportion of the QD constructs present; the cause of the decrease in
intensity. The QD constructs preferentially removed first would be the larger constructs. Removal
of the larger constructs would mean removal of the larger QDs and therefore removal of the source
of the larger emission wavelengths, all contributing to the decrease in CMW of the filtered
solution.
4.4.1.2 QD Construct Control and Test Solutions – R2
The effect of a more coagulated encapsulation mixture, like the one produced during the
encapsulations performed in R2, increased the difficulty for achieving an even distribution of QD
constructs within the keratinocyte media; consequently, less of the actual QD constructs passed
through the filter. The coagulation may also have led to less QDs actually being encapsulated,
causing the majority of what was passed through the filter to be congealed phospholipids without
any QDs. Comparison of the peaks for the filtered QD construct solutions, of R1 and R2, showed
that the R2 0.45 micron solution to be five times less intense than the R1 0.45 micron QD construct
solution. This difference would seem to support the conclusion that the encapsulation of the R2
solutions was not as effective as the R1 samples and that in future encapsulation proceedings,
measures should be ensure a less viscous end product. The dilution of the QD construct test
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solutions, during the encapsulation process, using the native keratinocyte media would be an
effective method for achieving this.
4.4.1.3 Optical Imaging – R1
The identity of the orbs that appeared in the keratinocyte cell cultures 24 hours after the
introduction of the test solutions remains unknown. An extensive literature and internet search of
common keratinocyte cell culture contaminants, as well as typical cell anomalies, did not return
any results that appeared similar in appearance or description. Based on the spherical and
concentric appearance of the orbs it was proposed by Dr. Kristen O’Halloran Cardinal that they
may in fact have been dead cells, but that without viewing them first hand it could be some
contaminant. The confocal images of the same cultures did not reveal an obvious presence of the
orbs, however, in the cultures that had been exposed to the QD construct test solutions, it was noted
that some of the structures that the QD constructs had attached to, could in fact be the orbs. The
image in Figure 4.39 is an example of the QD construct attachment to a structure similar to what
was previously described.

Figure 4.39 Taken with a digital camera through the eyepiece of the microscope with the wide
field fluorescent laser applied to well b3.10 (QD PL krt filtered).

The images of the seemingly burst cell in Figure 4.22, whether or not the cell had actual swollen up
to the point of bursting, can be positively identified as a cell. The interesting quality to notice in
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that image is that there is still a considerable amount of green visible around the cell from the
presence of the Calcein stain. This indicates that the cell was alive at the time of exposure to the
Calcein. The considerable amount of QD construct attachment around the periphery, and in the
interior live portion of the cell, supports the hypothesis that the constructs were able to permeate
the cell membrane. It does not however, provide substantial information from which to conclude
when the constructs permeated the membrane. One explanation is that perhaps the constructs
invade live cells causing cell death, and at the point of cell death, as enzymatic activity stops and
the presence of enzymes declines, the constructs no longer have a point of attachment and therefore
move out and away from the cells along with the cellular debris. This explanation could justify the
lack of QD constructs within the completely red cells and the varying degree of their presence with
respect to the amount of fluorescing Calcein.
The confocal images of the wells containing the unfiltered QD construct test solutions show
minimal evidence of attachment of QD constructs to culture components. The difference between
the images of the filtered and the non-filtered QD construct test solutions provide evidence for the
benefits of filtering the solution as a method for increasing the interaction between the cells and the
QD constructs. The nature of the phospholipids is such that when in large amounts they tend to
aggregate forming particles too large to effectively interact with the cells. The series of images
applying Qdot565 filter and the Alexa Fluor488 and PI filters for the different focal planes of the
same field of view indicate that the larger aggregates of QD constructs, though not appearing to
permeate any of the cells, appear to group around the cells; this is especially apparent in images A4
and B4 of Figure 4.27.
4.4.1.4 Optical Imaging – R2
The appearance of the cell cultures used in R2 were, on average, more confluent with larger
numbers of cell colonies than the cultures in R1. The appearance of the cultures, with respect to
126

contamination, was similar both before and after the administration of the test solutions. Taking an
extended series of images of the cells as viewed through the microscope, made the process of
comparing anomalies found in the confocal images with their possible source in the optical images.
4.4.1.5 Keratinocyte Cell Viability and Cell-QD Construct Interaction – R1
Confocal images with different focal depths illustrate the degree of and effect of the L/D
stain, indicating that many of the cells were alive at the time of the L/D stain was introduced to the
culture. Additionally different focal planes provide a method for uncovering the effects of the
EthD-1 stain at the earliest stages by looking at components of the cell both proximal and distal to
the nucleus. A factor worth noting is that although all of the wells in sub-set b1.1-4 were exposed
to the L/D stain at the same time, b1.3 was the third well in the sub-set to be imaged and therefore
had a longer exposure time than b1.1 would have. Averaging the time it took to acquire a series of
images for each well, well b1.3 had a minimum exposure of 25 minutes.
Direct comparison of the confocal images acquired for b1.1 versus those of b1.3 would
appear to support the hypothesis that the L/D stain may itself have a detrimental effect on the
viability of the keratinocyte cells and as a result be a factor in the ratio of dead to live cells,
however, the particular test solutions that each well was exposed to should also be taken into
consideration. Well b1.1 contained a control solution of fresh keratinocyte media whereas well
b1.3 contained keratinocyte media that had been mixed with CHCl3, heated at 55°C, and then
presumably had the CHCl3 evaporated off. It was noticed that the edges of the culture wells had a
greater density of cell coverage, less cell death via EthD-1 stain, but also less cell-QD interaction.
4.4.1.6 Keratinocyte Cell Viability and Cell-QD Construct Interaction – R2
Two additional characterization techniques were employed in R2 that had not been used in
R1: H/H staining and DIC imaging. Both of these proved to be helpful in distinguishing the
presence of the cells and the interaction of the QD constructs with the cells. Unfortunately, the QD
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construct solutions of R2 were not to the standard of the solutions used in R1. Throughout all of the
confocal imaging it was obvious that there was a decreased presence of QD constructs in the cell
culture relative to the concentration of QD constructs in the solutions used in R1. Figure 4.31 of
well a2.5 is especially effective at illustrating the difference between the two sets of QD-construct
test solutions; only a single QD construct is distinguishable. Use of Hoechst stain was applied as a
method for decreasing possibility for the misidentification of QD construct attachment to cells in
the likelihood of a reoccurrence of the QD interaction with possible non-cell entities as seen in the
R1 trials.
A difficulty encountered during the confocal imaging of cells in R2 that was not present in
R1 was a result of the four-well slides the cells had been cultured in. To acquire clear images of
the cells using the confocal microscope it was necessary that there only be a very thin barrier
between the cells and the objective lens. The thicker specimen slide base that the four-well in R2
were attached to prevented this. Among the alterations that had to be made to image the cells was
aspiration of the solution in each well. Aspiration of the solutions could have very likely
compromised the environment of the cultures, with respect to imaging, relative to what was seen in
R1. The preparation of the slide also introduced extra variables such as dehydration of the
samples, removal of QD constructs that were previously interacting with the cells, and shock to the
cells as a consequence of the removal process of the rubber septum. The application of the razor
blade for well-sets b and c, over the metal spatula used for well-set a, greatly decreased the time
and damaged, and increased the degree of complete removal of the rubber septum. This more
complete removal provided a better surface for the cover slip to attach to, thereby yielding better
images.
Application of the Qdot565 filter, for imaging the non-QD construct wells, aided in
assessing unknown factors which might be presumed to be QD constructs in the associated wells,
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but were actually artifacts related to some other presence within the culture. A subsequent effect of
using the Hoechst stain was the false registration of QD constructs. The excitation/emission
wavelength ranges of the Hoechst stain and the QD constructs were very similar. As a consequence
of this similarity the QD565 filter caught a portion of the emission form the Hoechst stain. This
emission was then falsely registered as a QD construct signature when in fact no QD constructs
were present; a circumstance that was supported by the application of the Hoechst and Qdot565
filters on wells that had not been exposed to any QD constructs. According to the image results
using the DAPI and Qdot565 filters on wells that were sans QDs, QD constructs were present.
Fortunately, the presence of the fluorescence in the image was not the sole factor for determining
the presence of the QD-constructs; the shape and structure of the image was also a method for
identification. The constructs, throughout all of the images in both sets of trials, consistently
displayed a distinct structure. This structure varied depending on the degree of filtration of the QD
construct solutions, but was none the less distinguishable relative to the keratinocyte cells. A
Hoechst stain affect was to use a higher excitation wavelength. Using an excitation wavelength of
488nm, rather than 405nm, provided a method for exciting any QD constructs that may have been
present that was outside the optimal range of excitation wavelengths needed to excite the Hoechst
stain.
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Chapter 5 – Discussion and Conclusions

5.1 Overview and Summary
Cancer is a prevalent and devastating health issue and the second leading cause of death in
the United States (2). The most common type of cancer found in the United States is skin cancer
(4). Early and accurate detection is the most reliable way to ensure a positive outcome and the
ultimate survival of the patient (5). Accurate determination of the presence of cancerous cells in a
biopsy is especially difficult at the early stages when only a small percentage of cells in the
biopsied mass show the morphological traits associated with being cancerous. This circumstance
often results in a false negative (FN), delaying the necessary treatment until the cancer has reached
a more developed stage (7). For this reason alternative methods for the identification of individual
cancer cells within a larger population of healthy cells is required; functionalized QD constructs
can be this alternative method. Already QDs have been investigated in in vitro and in vivo studies
as a viable method for the detection of cancerous cells within prostate, colon, and breast tissue
cultures (9, 10). The extensive investigations that are being conducted into the applications of QDs
for use as biologic tags and vehicles for targeting cancer, demonstrate the value that they offer.
Currently the CdSe/Zn QDs being synthesized at Cal Poly generate QDs with a wide range
of CMWs, intensities, and FWHMs. This ability to synthesize such a range of products
demonstrates the potential for developing a procedure for the consistent optimization of multiple
QDs that can then be used in specific biologic applications. By addressing some of the QD
synthesis challenges encountered and described in chapter 2, such as temporal wavelength shifts
and lowered intensities post-ZnS shelling, great strides will be made toward achieving a reliable
method for synthesis of QDs of consistent CMW and intensity.
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5.2 Challenges, Limitations, and Future Work
Of the three different sets of QD construct test solutions created, two of which are detailed
in this thesis, the third solution presented challenges during the filtration process. The initial
encapsulation mixture had an increased viscosity and decreases diffusion within the keratinocyte
media into which it had been suspended. This along with the introduction of the 0.2 micron filter in
the third set of trials resulted in QD-construct test solutions of decreased concentration. The
confocal images acquired of the keratinocyte cultures associated with this set of QD construct
solutions showed decrease in the presence of QDs and there interaction with the keratinocyte cells.
In future experiments every trial should contain test solutions that have been filtered with 0.8, 0.45,
and 0.2 micron filters to determine the degree to which each filter causes an effect on the QD
construct concentration and subsequent cell-QD construct interactions.
Working with fluorescent stains such as Calcein, EthD-1, and Hoechst presented challenges
for imaging of the culture trials. As a result of overlapping emission wavelengths the filters applied
to acquire the confocal images could not be used in concert with one another. the QD filter had to
be used separately form the Alexa Fluor488 and PI filters for detecting the L/D stain and the
excitation wavelength corresponding to the Qdot565 filter had to be exchanged for a higher
wavelength so as to not inadvertently excite the Hoechst stain and misidentify it as a QD.
Although all of these challenges were eventually overcome, it was by trial and error. In each of the
trials a new and useful characterization mechanism was added providing a more complete picture
of the effects of the QD construct test solutions on the keratinocyte cells. In future trials it would
be beneficial to add additional staining techniques for the determination of cell proliferation as well
as cell viability.
A long term study of the keratinocyte cell-QD construct interaction was not possible as a
result of the constraints related to maintaining an aseptic environment. Most of the cell cultures
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showed an initial amount of contamination pre-introduction of the test solutions and in some
instances this small amount of initial contamination became a prominent presence in the cultures
by the end of the 24 hour test period. Not only did the presence of contamination often cloud the
view, it also clouded the conclusions as to what was the primary factor affecting cell viability; the
QD test solutions or the contamination. Additionally some of the confocal images acquired of the
resulting keratinocyte cell-QD construct interactions presented questions as to what the QDs were
attaching to. Many of the structures that were initially assumed to be keratinocyte cells were, after
further trials had been conducted, later called into question. It was concluded that there was
evidence of QD construct attachment to both keratinocyte cells and the unidentified structures
(USs); even more so to the unidentified structures. This called into question why the QD constructs
seemed to have a greater affinity for the USs; a question that has remained unanswered. In future,
if a QD construct solution can be synthesized that is capable of being filtered through the
0.2micron filter, which is necessary to prevent contamination, without decreasing the concentration
of QD constructs within the solution, it may be possible to conduct trials with longer time points
and less contamination. Ultimately, once the procedure for encapsulating and filtering the QD
construct test solutions has been optimized, transition in to more complex biologics, such as
EpiDerm skin substitutes, will be the next adventure.

5.3 Conclusion
Although there are many journal articles describing and reviewing a variety of procedures
for the solubilization and phospholipid functionalization of CdSe/ZnS QDs for use in a biologic,
this thesis describes the first attempt of such an endeavor at Cal Poly. This method for synthesizing
QD constructs has great potential for applications where cellular tagging is desired or where
monitoring the migration of cellular components in real time is of interest. The current protocol
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being used at Cal Poly for the synthesis CdSe/ZnS QDs has proved to be a sufficient method for
supplying QDs that are compatible with phospholipid encapsulation. Further modifications of both
the CdSe/ZnS QD synthesis and optimization of the encapsulation protocol developed here, will
provide a multitude of future applications only limited by imagination.
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Appendix A - Abbreviations
BOs

black orbs

Cd

cadmium

CdSe

cadmium selenium cores

CHCl3

chloroform

H/H

Histochoice fixative and Hoechst stain

krt

keratinocyte

L/D

live/dead cytotoxicity/viability Calcein/Ethidium homodimer-1

MeOH

methanol

ODE

octadecene

PL

phospholipids

QD

quantum dots

R1

round one

R2

round two

Se-TOP

seleniuom trioctylphosphine

WFCs

white fluorescing CdSe cores

ZnS

zinc sulfide quantum dots
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Appendix B – Protocols and Experimental Details
B.1 – Cal Poly Standard CdSe/ZnS Synthesis Protocol and Analysis Procedure
The following CdSe/ZnS synthesis protocol and analysis procedure are the standard protocol and
procedure documented by Josh Angell and used by Cal Poly’s Biomedical Department.

Appendix A: CdSe Quantum Dot Synthesis
Reaction and Characterization Procedures
The first part of this procedure outlines 3 different techniques (Purging, Syringing, & Oil Bath
Operation) which are required for quantum dot synthesis.
The second part contains instructions to create the selenium/cadmium precursors and then
react them to synthesize CdSe quantum dots.
Chemicals
13 mg Cadmium Oxide Powder
33 mg Selenium Powder
0.6 mL Oleic Acid (tech grade 90%)
15 mL Octadecene (tech grade 90%)
0.4 mL Trioctylphosphine (tech grade 90%)
Toluene and Acetone for cleanup
Equipment
2 – 50mL 14/20 1-neck or 3-neck Round Bottom Flasks
2 – 1mL Disposable Plastic Syringes
2 – 3mL Disposable Plastic Syringes
1 – 5cc Glass Syringe, Luer Lock Tip
1 – Veterinary Tip, 18 gauge, 3” SS Needle
2 – Small Stir Bars
3 to 5 – 7.5 mL Borosilicate Vials
1 – Medium-Sized Beaker (150 mL)
2 to 4 – Rubber Septa
Hot/Stir Plate with RTD Probe
Crystallization Dish
~ 200 mL – High Temperature Silicone Oil
Chemical Spatula
Kimwipes
Thermocouple
Analytical Balance
Stopwatch
Latex or Nitrile Gloves
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Chemical Disposal
All chemicals and equipment used during the quantum dot synthesis must be properly disposed
of. Currently there is a vessel for liquid waste and a container for solid wastes such as needles,
syringes, kimwipes, etc. which are stored in the yellow, hazardous chemical cabinet in the
nanotech lab (Bldg. 41-205).

Preparing Chemical Bottles
1. Fill a clean dry bottle with the desired
chemical.
2. Fit a rubber septum into the top of the bottle.
3. Either purge the solution if it is to be used
immediately or store it for later use.
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Purging Procedure
This procedure is to be used for any chemical and/or reaction vessel needing purging.
1. Fill a large beaker with water until it is ¾
full.
2. Lower N2 tank gas escape hose into
beaker.

3. Fully open valve on top of tank.
4. Fully open left knob on valve.
5. Open middle knob on valve (“increase”)
until bubbles start to appear in the beaker.
Maintain this gas flow throughout the
procedure.

6. Insert N2 purge needle into center of
septum. Make sure the needle is above
the level of the liquid.
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7. Insert a vent needle into the septum next
to the N2 purge needle. Make sure it is
above the level of the liquid.

8. After inserting the vent needle, lower the
purge needle so that the tip is submerged
in the liquid. Bubbles should begin to
form in the liquid. If the needle cannot be
submerged below the level of the liquid,
either more chemical can be added or the
bottle can be carefully tilted.
9. Allow to bubble for at least 10 minutes to
remove oxygen from the chemical.
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Syringing Procedure
This procedure is a method of transferring a chemical from one purged vessel into another
without the introduction of oxygen. All solutions must be properly purged with N2 before
using this procedure.
1. Remove a disposable plastic syringe from
its packaging.

2. Pull the N2 purge needle up so that it is
above the level of the liquid. No bubbles
should be forming at this point.
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3. Insert the tip of the syringe into the
venting needle.
4. Draw N2 gas up into the syringe.

5. Remove the N2 filled needle and syringe
from the septum and fully expel all the
N2 gas by plunging the syringe down.
Make sure to expel the syringe away from
yourself in the hood.
6. Reinsert the needle and syringe into the
septum.
7. Repeat the filling and expelling process
twice more. This removes any oxygen in
the syringe.
8. Reinsert the needle and syringe then pull
up the syringe to once again fill the
syringe with N2. Do not remove the
syringe from the flask.
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9. Fully pull out the N2 purge needle.

10. Plunge down the N2 filled syringe to
create positive pressure in the vessel.
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11. Invert the chemical vessel and syringe.
12. Slowly draw out the desired amount of
solution into the syringe. Make sure to
keep the needle tip in the liquid to prevent
gas from entering the syringe.

13. Quickly and carefully insert the needle
into the center of the septum of the
desired vessel and slowly plunge down
until all the liquid is expelled.
14. If more of the purged chemical is needed,
quickly reinsert the syringe into the
purged solution and draw out more
chemical.
15. Chemicals must be repurged if left for
longer than 10 minutes.
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Oil Bath Operation
1. Fill crystallization dish with ~200 mL
high temperature silicone oil.
2. Place dish on hot plate.
3. Put paper clip into dish, which will act as
a stir rod for the oil.
4. Clamp RTD probe in clamp on ring stand
so that it is in the oil bath without
touching the glass.

5. Press heater button on plate.
Set to desired temperature.
Allow ~30 minutes to reach temperature
and stabilize.
Temperature in flask will be offset from
setting on plate by ~17 °C lower.
(i.e. set: 225 °C flask: ~208 °C)
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6. Put stir bar into reaction flask. Put
thermocouple into the flask at this point if
necessary, sealing it between the glass
and the septum.
7. Put septum onto flask to seal it.
8. Clamp reaction flask in 3-finger clamp.
9. Lower the reaction flask into the oil bath.
Make sure the flask is not touching the
bottom of the dish.

10. Press stirrer button on plate.
Set to desired stir speed.
11. When finished with reaction, turn off
heater and stirrer.
12. Raise clamped flask out of oil bath and
clean oil off with kimwipe with toluene
and then acetone.
13. Allow oil bath to come to
room temperature.
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Se-TOP Procedure
1. Purge Octadecene (ODE) following the
Purging Procedure for ~15 minutes.
2. Weigh out 33 mg Se powder into a 50
mL round bottom flash. Make sure the
flask is clean and dry.
3. Drop a small stir bar in the flask. Cap
flask with a rubber septum.

Do NOT breathe in Selenium fumes.
4. Clamp the neck of the flask in a 3-finger
clamp on ring stand.
5. Set heat to 150 °C.
6. Purge the flask with N2 gas by inserting
the purge needle followed by a venting
needle. Allow to purge for 10 minutes.
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7. Transfer 5 mL ODE into the flask using
the Syringing Procedure.
8. Lower flask into oil bath.
9. Set stir to 500 rpm.
10. Begin purging trioctylphosphine using
the Purging Procedure.
Purge for ~15 minutes.
11. Using the Syringing Procedure, add
0.4 mL of purged TOP to the Se-TOP
reaction flask. The majority of the
selenium should dissolve immediately.
12. Continue stirring at 150 °C until the
solution is completely clear. If all the
selenium does not dissolve, it may be a
sign that oxygen was introduced into
the reaction and oxidize the TOP
before the selenium and TOP can
react.
13. Remove the solution from the oil bath
and pull out the N2 needle and vent
needle.
14. Once it has cooled, clean the outside
of the flask with toluene and acetone.
This SeTOP solution can be stored for
up to a week and makes enough
SeTOP precursor for five QD
syntheses.

155

Cd-Precursor Procedure
1. Weigh out 13 mg of CdO into a 50 mL
round bottom flask.
2. Put a small stir bar into the bottom of
the flask.

Cadmium Oxide is Toxic. Do NOT breathe fumes.
3. Insert a thermocouple so that the wire
almost touches the bottom of the flask.

156

4. Place a rubber septum onto the flask
and fold over the edges to firmly
secure the thermocouple.
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5. Clamp the flask in a 3-finger clamp on
a ring stand and begin purging with N2
using the Purging Procedure.
Purge for ~10 minutes.

6. Set heat on oil bath to 242 °C
(Adjust as needed to achieve 225 °C in
flask).

7. Using the Syringing Procedure, add 10 mL of purged ODE into the flask.
8. Lower the flask into the oil bath.
9. Set the stir function to 500 rpm.
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10. Purge the Oleic Acid using the Purging Procedure for ~10 minutes.
11. Using the Syringing Procedure, add 0.6 mL Oleic Acid to the Cd reaction flask.
12. Heat until solution becomes optically clear. CdO has a tendency to stick to the walls of
the flask, so the flask should be agitated occasionally to prevent build up on walls.

The chemicals in this reaction mixture become volatile around 200 °C.
Do NOT breathe fumes.
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Sample Removal
Caution: This process requires safely handling high-temperature organic, volatile
chemicals. Two people must be present and all those present must wear appropriate
safety equipment at all times.

Prepare syringes and vials while the Cd precursor is heating.
1. Attach one metal needle tip securely to
a plastic 3 mL syringe and one to a
glass 5 mL syringe with Luer lock.

2. Remove the caps from clean, dry vials.
3. Once the Cd precursor becomes
optically clear, ensure that its
temperature is stable at 225 °C (adjust
hot plate setting as needed to achieve
stability at 225 °C).

4. Once stable at 225 C, quickly inject 1
mL of room-temperature Se-TOP
precursor into the hot Cd precursor.
Start timing when the SeTOP precursor
is injected.
A white fog will immediately form and
the solution will begin changing color to
a pale yellow.
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5. Using the glass syringe, carefully
remove samples of 0.5 to 3 mL at
desired time intervals.
6. Put samples into separate vials.

7. Cap and label the vials, indicating
quantum dot type, date synthesized,
reaction time, and absorbance
wavelength.
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Fiber Optic

Spectrometer
LED Power
Supply

Sample Holder
388nm LED

This procedure is a method for gathering quantitative information about the distribution of quantum dots
relative to their size when suspended in solution by utilizing photon excitation and fluorescence.
1.

Make certain that the 388nm LED is plugged in and turned on to its maximum brightness to warm
up the light source before data acquisition is initiated.

2.

Connect the sample holder to the spectrometer and the spectrometer to the computer. Open the
Spectra Suite software.
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3.

With the LED on, but the sample holder empty,
take a dark spectrum reading by clicking on the unlit
light bulb icon.

4.

Click on the icon containing both a “-“ and an unlit
light bulb. This subtracts the background noise
preventing its influence on the QD readings.

5.

Place a minimum of 2 mL of the QD solution to be
tested into a clean cuvette. Place the cuvette inside the
cuvette holder making certain to secure it in place.

6.

Click on the icon of two line pieces of paper to copy the resulting fluorescence spectra
clip board, then transfer this data onto an Excel spread sheet for further
analysis.

7.

Using the cursor, click on the fluorescence peak at its maximum value; this is your center max
wavelength (CMW). Divide the intensity value associated with the CMW by two. Find the
wavelength values on each side of the peak associated with this new intensity value. The difference
between the two wavelength values is the full width at half max (FWHM).
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onto the

B.2 - Absorbance Measurement Procedure
Materials:


Spectra Suite Software



Ocean Optics USB 4000 UV-Vis spectrometer



DH 2000 BAL light source: combines the output of deuterium and tungsten halogen sources
into a single optical path from 215 – 2000nm.



Quartz cuvette – 1cm path length (glass or disposable plastic cuvettes may also be used)



Two 400 micron optical fibers



Sample holder
*When not actively taking measurements turn the toggle switch on the light source to the close
position to prevent inadvertent exposure to the light source.

Procedure:
1. Use two 400 micron optical fibers at 180° relative to one another, one to transmit light from
the source to the sample and one to transmit light from the sample to the spectrometer.
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2. Load the Spectrsuite software, and then turn on the light source by flipping the power switch
at the back.

3. Press the blue button to turn on the deuterium source.
The light will blink momentarily while the source is warming up. When the light stops blinking
turn on the tungsten halogen source by pressing the red button. Allow the light source 20 to 30
minutes to completely warm up.

4. Moving the toggle switch to the open position will open the magnetic shutter and allow the
light to move through the optic fiber and interact with the sample.
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5. To create a reference spectrum insert a cuvette with 3mL of the solvent into the sample holder.
When using CdSe/ZnS QDs synthesized using the standard protocol, the reference solvent will
be ODE.
6. Open a new “Absorbance” file.
7. Move the toggle switch to the open position.
8. Click on the yellow light bulb icon in the control panel. This will store the reference spectrum.

9. Move the toggle switch to the closed position.
10. Click on the grey light bulb icon in the control panel. This will store the dark spectrum.
The processing mode icons will now turn dark blue indicating that they are active.

11. Click on the “ ” icon in the control panel.
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Once the absorbance processing mode has been initiated, a spectrum similar to the one shown
above should appear, indicating an absorbance measurement of zero.
12. Remove the reference sample cuvette of solvent.
13. Place in the test sample cuvette.
14. Set the integration time to a value where the entire spectrum can be seen. For ODE this is
approximately 5ms.

15. Set the scanning average value to 10. This reduces the signal to noise ratio.
16. Set the box car value to 2. This smooths out the signal.
The absorbance spectrum for ODE should appear to be similar to the spectrum shown below.

Additional Information
For additional methods of acquiring absorbance measurements refer to the tutorial provided on
the Ocean Optics website at http://www.oceanoptics.com/videos/absorbance.htm.
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Appendix B.3 - Wavelength Specific CdSe and CdSe/Zn Synthesis
All of the following synthesis directions are given with the assumption that the standard
CdSe/ZnS synthesis procedure given in Appendix B.1 has been read and understood.
Procedures:
White Fluorescing CdSe Cores
1. Use single batch amounts of Cd and Se-TOP precursor, 10 and 1mL respectively.
2. Heat Cd precursor to a minimum of 215°C and add 1mL of the Se-TOP precursor.
3. Extract a 5mL sample no more than 15 seconds after injection of the Se-TOP precursor and
deposit the sample into a 15mL glass vial.
*Temperatures greater than 215°C can be used.
545 ± 5nm CdSe Cores
1. Use single batch amounts of Cd and Se-TOP precursor, 10 and 1mL respectively.
2. Heat Cd precursor to 215°C and add 1mL of the Se-TOP precursor.
3. Extract a 5mL sample 60 seconds after injection of the Se-TOP precursor and deposit the
sample into a 15mL glass vial.
555 ± 5nm CdSe Cores
1. Use single batch amounts of Cd and Se-TOP precursor, 10 and 1mL respectively.
2. Heat Cd precursor to 225°C and add 1mL of the Se-TOP precursor.
3. Extract a 5mL sample 60 seconds after injection of the Se-TOP precursor and deposit the
sample into a 15mL glass vial.
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495 ± 5nm CdSe/ZnS QDs
1. Heat 5mL of white fluorescing CdSe cores to 110°C for 10 minutes.
2. After 10 minutes of heating add 1mL ZnS precursor drop-wise over a period of 2 minutes;
heat for an additional 8 minutes for a total synthesis time of 20 minutes.
3. Remove the solution from the heat and when the internal temperature reaches 60°C, quickly
add 1mL of butanol.
540 ± 5nm CdSe/ZnS QDs
1. Heat 5mL of white fluorescing CdSe cores to 160°C for 10 minutes.
2. After 10 minutes of heating add 1mL ZnS precursor drop-wise over a period of 2 minutes;
heat for an additional 8 minutes for a total synthesis time of 20 minutes.
3. Remove the solution from the heat and when the internal temperature reaches 60°C, quickly
add 1mL of butanol.
560 ± 5nm CdSe/ZnS QDs
1. Heat 5mL of 550nm CdSe cores to 110°C for 10 minutes.
2. After 10 minutes of heating add 1mL ZnS precursor drop-wise over a period of 2 minutes;
heat for an additional 8 minutes for a total synthesis time of 20 minutes.
3. Remove the solution from the heat and when the internal temperature reaches 60°C, quickly
add 1mL of butanol.
570 ± 5nm CdSe/ZnS QDs
1. Heat 5mL of 550nm CdSe cores to 160°C for 10 minutes.
2. After 10 minutes of heating add 1mL ZnS precursor drop-wise over a period of 2 minutes;
heat for an additional 8 minutes for a total synthesis time of 20 minutes.
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3. Remove the solution from the heat and when the internal temperature reaches 60°C, quickly
add 1mL of butanol.

Additional Information
White fluorescing CdSe cores have an emission shift over time; therefore, if they are synthesized
for later ZnS shelling they should be used within 10 days of synthesis. ODE can be added to
CdSe/ZnS QDs with low intensities as a means of increasing the intensity but care should be
taken to record and tract these alterations for future sample comparisons.
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B.4 - Precipitation and Resuspension of CdSe/ZnS Quantum Dots
Materials:


Absolute ethanol



Chloroform



2 – 4 capped 15mL centrifuge tubes



Premiere Centrifuge XC-2000



3mL syringe



Vortex



Metal reagent spatula

Procedure:
Precipitation
1. Select CdSe/ZnS QD sample of interest suspended in ODE.
2. Divide the QD sample among an even number of centrifuge tubes with equal amounts of QD
solution in each tube.
3. Add an amount of ethanol to each centrifuge tube that is equal to twice the amount of QD
solution in each tube.
4. Cap and vigorously shake each tube.
5. Place all tubes, evenly distributed, in the centrifuge and spin at 4000 RPMs for 10 minutes.
6. Remove the supernatant. Begin removal with the syringe’s needle at the surface of the
supernatant to ensure the removal of the ODE.
7. Add an additional quantity of ethanol equal to the initial amount used in step 3. Inject the
ethanol quickly to promote agitation of the solution; if available vortex the solution.
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8. Repeat step 5 through 7 until a pellet of QDs have been securely precipitated into the tip of the
centrifuge tube.
9. When an adequate precipitate is achieved, pour out the remaining supernatant.\
10. Place the centrifuge tubes, uncapped, in the fume hood for complete evaporation of any
remaining supernatant.
Resuspension
1. Select a centrifuge tube with a completely dry precipitate in the tip.
2. Using a metal reagent spatula, carefully remove any black precipitate that may be present.
3. Add an amount of chloroform to the precipitate equal to the initial volume of QD solution; i.e.
if the initial solution in each centrifuge tube was 2.5mL, add 2.5mL of chloroform.
4. Wait for QD precipitate to be completely suspended in chloroform.
Additional Information
If after addition of the chloroform the QDs continue to precipitate out of solution it may be
necessary to perform the precipitation procedure a second time. Continual precipitation of the
QDs out of the chloroform indicated that ethanol may still be present.
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Appendix B.5 - Quantum Yield Calculation
Materials:


1 mg of fluorescein reference standard



6mL of ethanol



Sonicator



6mL of octadecane (ODE)



9mL of a CdSe/ZnS QD sample



10 cuvettes (disposable plastic cuvettes may be used)



Cuvette tray



UV – Vis spectrometer



Spectra Suite software

Procedure:
Fluorescein Dilution
The optimal concentration is 20µg/mL of fluorescein/ethanol. As a result of the limits of
measurement inherent to many analytical scales, larger amounts of fluorescein may be measured
out and the appropriated concentration arrived at through a series of dilutions. For instance, 1mg
fluorescein diluted in 5mL of ethanol yields a concentration of 200µg/mL. Further dilution can
be achieved by taking 1mL of this and adding to it 9mL of ethanol. The resulting solution will
have the desired concentration of 20µg/mL of fluorescein/ethanol.
1. Put on gloves!
2. Weigh out 1mg of fluorescein on an analytical balance. Place in a 10mL glass vial.
3. Add 5mL of ethanol and securely cap the glass vial.
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4. Lower the solution into a sonicator for 30 seconds.
5. Remove 1mL of the fluorescein/ethanol solution and place it in a 15mL glass vial.
6. Add 9mL of ethanol and securely cap the glass vial.
7. Lower the solution into a sonicator for 30 seconds or until an even distribution is observed.
This is your starting stock solution of fluorescein to be later diluted for the purpose of
achieving a graphed linear line from which the slope will be used to calculate quantum yield.
CdSe/ZnS Quantum Dot and Fluorescein Dilution
Starting with a stock solution to be used as the 100% concentration standard from which all other
dilutions will be made, 5 different concentrations, of both the QD sample and the
fluorescein/ethanol sample, will be created: 100, 80, 60, 40, and 20%.
1. Set aside 3mL of the 9mL stock QD solution, this will be used as your 100% concentration
solution. Set 3mL of this solution aside in a cuvette.
2. Take the other 6mL of the QD sample and add 1.5mL of ODE for a total of 7.5mL of an 80%
concentration. Set 3mL of this solution aside in a cuvette to be used as your 80%
concentration.
3. Take the other 4.5mL of 80% solution and add 1.5mL of ODE for a total of 6mL of a 60%
concentration. Set 3mL of this solution aside in a cuvette to be used as your 60%
concentration.
4. Take the other 3mL of the 60% solution and add 1.5mL of ODE for a total of 4.5mL of a 40%
concentration. Set 3mL of this solution aside in a cuvette to be used as your 40%
concentration.
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5. Take the other 1.5mL of the 40% solution and add 1.5mL of ODE for a total of 3mL of a 20%
concentration. An example of the progression of dilutions where 6mL of 100% concentration
+ 1.5mL of ODE = 7.5mL of 80% concentration is given in Table B.5.1.
Table B.5.1 Concentration and Dilution Calculation Table

QD (mL)
3
6
4.5
3
1.5

%
100
100
80
60
40

ODE (mL) QD (mL)
0
3
1.5
7.5
1.5
6
1.5
4.5
1.5
3

%
100
80
60
40
20

6. Repeat this same series of dilutions starting with 6mL of 100% concentration
fluoresceing/ethanol, adding 1.5mL of ethanol for a total of 7.5mL of 80% concentration, etc.
Excel Spreadsheet Calculation Using Fluorescence Spectrums
1. For greater ease, line up the cuvettes containing each set of concentrations in the cuvette trays
in order from 100 to 20% concentration.
2. Set the UV-Vis spectrometer to measure fluorescence.
3. Obtain a fluorescence spectrum for each of the ten samples and store the raw data in a wellorganized and labeled Excel spreadsheet.
4. Calculate the area under each fluorescence peak. This can be accomplished by using the
sequence “=(SUMPRODUCT(C3:C6,B4:B7)-SUMPRODUCT(B3:B6,C4:C7)+B7*C7B3*C3)/2” as it corresponds to the example data given in Table B.5.2. In this example the
area under the peak would be 4100 (no units).
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Table B.5.2 Sample Data for Calculating the Area Under a Fluorescence Spectral Peak

3
4
5
6
7

B
wavelength
(nm)
10
20
30
40
50

C
intensity
(counts)
10
100
200
100
10

Absorbance Spectrum Analysis
1. Set the UV-Vis spectrometer to measure fluorescence.
2. Obtain an absorbance spectrum for each of the ten samples and store the raw data in a wellorganized and labeled Excel spreadsheet for later reference if necessary.
3. For each sample set pick one wavelength value, for example 388nm, and find the
corresponding O.D. value on the y-axis as illustrated in Figure B.5.1. Use the same
wavelength value for each spectrum within the set.

Figure B.5.1 Corresponding O.D. and wavelength values on an absorbance spectrum.
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4. Make a table in Excel of the paired values of each set for each concentration.
5. For each set of five concentrations, QD sample and fluorescein/ethanol sample, you will plot
the fluorescence area value versus the O.D. absorbance value at each concentration. Do this
for the QD data and for the fluorescein/ethanol data. Add a regression line with equation on
each plot. The resulting equation will look something like y = -4E07x + 2.3566 for the QD
sample set and y = 3E07x – 0.0596 for the fluorescein/ethanol sample set. The value in front of
the x, for example -4E07, is your slope m for the QD sample set and slope mR for the
fluorescein/ethanol sample set.
Quantum Yield Calculation
Using the quantum yield value associated with the fluorescein reference standard as QR, the
index of refraction of the QD solvent n, the index of refraction of the reference solvent nR, and
the corresponding QD and fluorescein slopes obtained from the previously plotted data, m and
mR respectively, use Equation B.5.1 to calculate the comparative quantum yield of the QD
sample, Q.

(

)( )

Equation B.5.1

Additional Information
When using CdSe/ZnS QD samples of less than 10mL, additional concentration and dilution
scenarios can be easily calculated using the Dilution Calculator of Mass Concentration found at
the website:

http://endmemo.com/bio/dilution.php
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A less exact but preliminary quantum yield can be calculated for a single concentration, instead
of the previous example using a series of five concentrations, using Equation B.5.2 where I is the
integrated fluorescence intensity of the fluorescence spectrum and OD is the optical density
value of the absorbance spectrum.

( )(

)( )

Equation B.5.2

178

Appendix B.6 Solubilization and Phospholipid Encapsulation of CdSe/ZnS Quantum Dots
The following is a standardized protocol for creating a solution of phospholipid (PL)
encapsulated QDs (QD constructs) in an aqueous medium at a concentration of 10mg/mL of
phospholipids relative to the aqueous medium. The ratio of QDs to PLs and the concentration of
PLs relative to the aqueous medium can be further adjusted to suit particular needs, however, it is
recommended that a concentration of 10mg/mL of PL/aqueous medium is not exceeded.
Materials:


Fonterra 700 Phospholipid Mix



Chloroform (CHCl3)



Aqueous medium (AM)



50mL glass beaker



15mL glass vials (minimum of 2)



Silicon oil heat bath



Magnetic spin vane



Analytic scale



QDs precipitated from a 5mL sample

Procedure:
1. Wear gloves!
2. Resuspend the QDs in chloroform using the procedure given in Appendix B.4. This will result
in 5mL of QDs suspended in chloroform.
3. Weigh out 100mg of phospholipids in a 15mL glass vial.
4. Add 10mL of chloroform to the vial containing the phospholipids.
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5. Mix the QD/CHCl3 and phospholipids/CHCl3 together in the 50mL Beaker.
6. To maintain the initial concentration of PL, add an amount of AM equal to that of the
chloroform used in the original suspension. In this case add 10mL of the AM.
7. Set the magnetic stirrer to 200 RPM and place the beaker into the silicon oil bath after the bath
has reached an equilibrium temperature of 55°C. Position the beaker at an angle in the bath to
promote agitation of the solution thereby increasing the rate of evaporation of the chloroform.
8. Monitor the solution for a change in consistency. The higher the concentration of PL the
thicker the resulting solution will be.
9. Raise the beaker out of the silicon bath after 15 minutes and inspect for the presence of
chloroform. When all chloroform appears to have been evaporated remove the beaker and
place the solution into a clean 15mL glass vial.
Additional Information
Concentrations of PL/AM of 2.5mg/mL using a 2:1 milliliter ratio of PL/CHCl3:QD/CHCl3 was
seen to have the most consistent results in previous trials and should be further investigated for
use in any biologic applications.
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Appendix B.7 Introduction of QD Construct Test Solutions to Keratinocyte Cell Cultures
Materials:


Keratinocyte cells cultured on thin four-well slides



QD construct test solutions



Keratinocyte media



Aspirator



Incubator



Optical microscope



Digital camera or image capturing software and connected laptop

*All used with and aspirated off of the keratinocyte cells should be disposed of properly in a
biohazard waste receptacle in accordance with Cal Poly guidelines and State law.
Procedure:
1. Place all test solutions in a water bath set to 37°C for at least 10 minutes before introducing
them to the cell cultures.
2. Inspect cell cultures under an optical microscope to check confluency and to inspect for
evidence of contamination. Cells should be at least 60% confluent with minimal
contamination.
3. If the cells are deemed to be appropriately confluent, inspect each culture using the optical
microscope; do this before removing any of the culture media. Note confluency, cell colony
density, and cell shape throughout the culture as well as any abnormalities or unidentified
entities that may be present.
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4. Take three images of each culture for an accurate and thorough representation of all cell and
culture characteristics. *If using a digital camera, use the highest focus, no flash, and position
the camera’s lens just above the microscope eyepiece adjusting the aperture of the microscope
as needed. Taking an initial picture of the four-well slide before commencing with taking
images of the cells can aid in maintaining an accurate record.
4. Aspirate off the old culture media and add test solutions. Each round of trials should include at
least one well, in every four-well set, that is kept as a control and therefore receives only fresh
media.
5. Place the cells back into the appropriate incubator for the prescribed time point.
6. At the end of the experimental time point, remove the cells from the incubator and repeat steps
2 and 3, recording observations as well as taking images before removal of the test solutions.
7. Aspirate off the test solutions and rinse the cells twice with 1.5mL of keratinocyte media
leaving the second 1.5mL of media in place. Repeat steps 2 and 3.
8. Using the procedures outlined in Appendices 8 and 9, fix and stain the cells for inspection
under the confocal microscope.
Additional Information
The following are possible test solution and time point arrangements, previously described in
Chapter 4, that can be used exactly as described or altered as needed:
Table 4.2 Summary of Round Two QD Construct Control and Test Solutions
Well

Test Solution

a, b, c1.1 Control - krt media
a, b, c1.2 42612oEN.1a: PL/krt
a, b, c1.3 PL/krt

Filter

[10mg/mL]
[10mg/mL]
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0.2µm
0.2µm

Stain
(a)
H/H
H/H
H/H

Stain
(b)
L/D
L/D
L/D

Stain
(c)
H/H
H/H
H/H

a, b, c1.4
a, b, c2.5
a, b, c2.6
a, b, c2.7
a, b, c2.8

52312EN45.60b: PL/krt [10mg/mL]
42612oEN.1a: PL/krt [10mg/mL]
Control - krt media
52312EN45.60b: PL/krt [10mg/mL]
PL/krt
[10mg/mL]

0.2µm
0.45µm
0.45µm
0.45µm

Table 4.3 Keratinocyte Trial Time Points in Round Two
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H/H
L/D
L/D
L/D
L/D

L/D
H/H
H/H
H/H
H/H

H/H
L/D
L/D
L/D
L/D

B.8 - Preparation and Application of Histochoice and Hoechst Stain
The following protocol was acquired and adapted from the Cal Poly BMED 515 Fluorescence
Imaging Lab#1.
Materials:


Four-well slides of keratinocyte cells at 60% or greater confluency



Phosphate-buffered saline (PBS), pH 7.4



Histochoice



Hoechst Stain – Invitrogen 34580 (392/440)



15mL glass vial



Aluminum foil

Procedure:
Fixation of Cells
1. Put on gloves!
2. Aspirate off the existing media. Gently wash cells twice with 1.5mL of PBS. Aspirate off
PBS after each rinse including the last.
3. Add 1.5mL Histochoice to each well. Fix the sample in Histochoice for 30 minutes at room
temperature and covered. Prepare the Hoechst stain while incubating the cells in
Histochoice.
4. At the conclusion of the 30 minute incubation time aspirate off the Histochoice, rinse twice
with PBS, and aspirate off the PBS.
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Preparation of Hoechst Stain
1. Prepare a 2µg/mL concentration of the Hoechst dye; 1µL of stock solution to 2.5mL of PBS.
The stock solution is 5mg/mL. Prepare 400µL of solution for each well. 1µL of stock
solution to 2mL of PBS.
2. Mix solution in 15mL glass vial, securely cap, and vortex. Wrap vial in aluminum foil and
store in a dark container until use.
3.

Pipette the staining solution on to the surface of each well and incubate covered inside a
darkened container for 15 minutes.

4. Remove the stain by gently rinsing the well twice with 1.5mL of PBS, aspirate off the PBS
each time including the last.
5. When finished, aspirate off all remaining solutions and dispose of the four-well slides in the
designated biological waste container.
Additional Information
Image the cells of each well using the confocal microscope filter setting DAPI. If using the DAPI
filter in concert with a Qdot filter, set the excitation wavelength of the Qdot filter to 488nm to
reduce excitation of the Hoechst stain.
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B.9 - Preparation and Application of Live/Dead Viability/Cytotoxicity Stain
The following protocol was acquired and adapted from the Cal Poly BMED 515 Fluorescence
Imaging Lab#2.
Materials:


Four-well slides of keratinocyte cells at 60% or greater confluency



Keratinocyte cell media



Live Stain: Invitrogen Calcein AM (495/515nm)



Dead Stain: Invitrogen Ethidium homodimer-1 (EthD-1) (495/635nm)



15mL glass vial



Aluminum foil

Procedure:
Prepare Live/Dead Viability/Cytotoxicity Stain
1. Put on gloves!
2. Add 20µL of the supplied 2mM EthD-1 stock solution to 10mL of keratinocyte media in a
15mL glass vial. This gives an approximately 4µM EthD-1 solution. Cap and mix the
solution thoroughly via vortexing.
3. Combine the reagents by transferring 5µL of the supplied 4mM Calcein AM stock solution.
Cap and mix the solution thoroughly via vortexing. This results in an approximately 2µM
Calcein AM and 4µM EthD-1 working solution.
4. Wrap vial in aluminum foil and store in a dark container until use.
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Cell Preparation
1. Aspirate off the media in each well. Gently wash each well twice with 1.5mL of keratinocyte
media. Aspirate off the media each time. Add an additional 1.5mL of media to each well.
2. Cover each four-well slide until application of the fluorescence stain.
Label Cells
1. Gently add the fluorescence stain to cells. Add 1.5mL of Live/Dead working solution to each
well of the four-well slide no more than 15 minutes before imaging; this gives a final
concentration of 1µM Calcein AM and 2µM EthD-1.
2. Incubate the cells for 5-15 minutes at room temperature in a covered container protected
from light.
3. Image cells using the confocal microscope with filter settings Alexa Fluor488 for Calcein
live stain and PI for EthD-1 dead stain.
4. When finished, aspirate off all remaining solutions and dispose of the four-well slides in the
designated biological waste container.
Additional Information
The effect of the L/D stain on the cells can be monitored by examining the cells at multiple
intervals of time after the introduction of the stain. This temporal monitoring can aid in the
determination of the initial cell viability and the influence, if any, of the stain on the viability of
the cells.
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